Disease
MONDO:0000001A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.
Also known as: condition, disease, disease or disorder, disease or disorder, non-neoplastic, diseases, diseases and disorders, disorder, disorders
106141 clinical trials for this condition and its sub-types, 738 tagged with Disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease
-
Human disease 15 trials · 106,065 incl. sub-types
4 sub-types
- Disease by body system or component 0 trials · 94,022 incl. sub-types Sub-types →
- Disease by etiologic mechanism 0 trials · 60,180 incl. sub-types Sub-types →
- Disease by developmental or physiological process 0 trials · 36,262 incl. sub-types Sub-types →
- Acute disease 23 trials · 4,756 incl. sub-types Sub-types →
-
Non-human animal disease 0 trials · 48 incl. sub-types
55 sub-types
- Integumentary system disorder, non-human animal 0 trials · 15 incl. sub-types Sub-types →
- Hereditary disease, non-human animal 0 trials · 9 incl. sub-types Sub-types →
- Metabolic disease, non-human animal 0 trials · 9 incl. sub-types Sub-types →
- Sheep disease 0 trials · 9 incl. sub-types Sub-types →
- Infectious disease, non-human animal 0 trials · 7 incl. sub-types Sub-types →
- Cattle disease 0 trials · 6 incl. sub-types Sub-types →
- Nervous system disorder, non-human animal 0 trials · 6 incl. sub-types Sub-types →
- Inflammatory disease, non-human animal 0 trials · 5 incl. sub-types Sub-types →
- Nutritional disorder, non-human animal 0 trials · 5 incl. sub-types Sub-types →
- Digestive system disorder, non-human animal 0 trials · 4 incl. sub-types Sub-types →
- Goat disease 0 trials · 4 incl. sub-types Sub-types →
- Cancer or benign tumor, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Disorder of visual system, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Endocrine system disorder, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Swine disease 0 trials · 3 incl. sub-types Sub-types →
- Disorder of orbital region, non-human animal 0 trials · 2 incl. sub-types Sub-types →
- Dog disease 0 trials · 2 incl. sub-types Sub-types →
- Auditory system disorder, non-human animal 0 trials · 1 incl. sub-types Sub-types →
- Fish disease 0 trials · 1 incl. sub-types Sub-types →
- Musculoskeletal system disorder, non-human animal 0 trials · 1 incl. sub-types Sub-types →
- Non-human primate disease 0 trials · 1 incl. sub-types Sub-types →
- Acute disease, non-human animal 0 trials Sub-types →
- Bird disease 0 trials Sub-types →
- Cardiovascular disorder, non-human animal 0 trials Sub-types →
- Cat disease 0 trials Sub-types →
- Chromosomal disorder, non-human animal 0 trials Sub-types →
- Connective tissue disorder, non-human animal 0 trials Sub-types →
- Disease related to transplantation, non-human animal 0 trials
- Disorder of development or morphogenesis, non-human animal 0 trials Sub-types →
- Disorder of glycosylation, non-human animal 0 trials Sub-types →
- Hematologic disorder, non-human animal 0 trials Sub-types →
- Horse disease 0 trials Sub-types →
- Iatrogenic disease, non-human animal 0 trials Sub-types →
- Idiopathic disease, non-human animal 0 trials Sub-types →
- Immune system disorder, non-human animal 0 trials Sub-types →
- Lameness, non-human animal 0 trials
- Mammary gland disorder, non-human animal 0 trials Sub-types →
- Mitochondrial disease, non-human animal 0 trials Sub-types →
- Mouth disorder, non-human animal 0 trials Sub-types →
- Narcolepsy, non-human animal 0 trials Sub-types →
- Obstetric disorder, non-human animal 0 trials Sub-types →
- Occupational disorder, non-human animal 0 trials
- Otorhinolaryngologic disease, non-human animal 0 trials Sub-types →
- Perinatal disease, non-human animal 0 trials
- Poisoning, non-human animal 0 trials
- Post-infectious disorder, non-human animal 0 trials Sub-types →
- Premature aging syndrome, non-human animal 0 trials Sub-types →
- Psychiatric disorder, non-human animal 0 trials Sub-types →
- Radiation-induced disorder, non-human animal 0 trials
- Reproductive system disorder, non-human animal 0 trials Sub-types →
- Respiratory system disorder, non-human animal 0 trials Sub-types →
- Rodent disease 0 trials Sub-types →
- Syndromic disease, non-human animal 0 trials Sub-types →
- Ulcer disease, non-human animal 0 trials Sub-types →
- Urinary system disorder, non-human animal 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 15595 trials in this tab.
-
Can a common antiseptic outperform standard wart treatment?
Cure Not yet recruitingResearchers compare two topical treatments for plantar warts: hydrogen peroxide 40% applied once weekly and salicylic acid 40% applied daily. The trial enrolls 70 people aged 12 and older with clinically diagnosed plantar warts. The main goal is to see how many participants achie…
Phase 3 • Sponsor: Assiut University • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Half-Matched stem cell transplants tested as a cure path for older aplastic anemia patients
Cure Not yet recruitingResearchers are testing a conditioning regimen built around thiotepa before a haploidentical, or half-matched, stem cell transplant in people aged 50 and older with severe aplastic anemia. The regimen also includes busulfan, fludarabine, anti-thymocyte globulin, and basiliximab, …
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
One shot of gene therapy aims to fix a rare Muscle-Weakening disease
Cure Not yet recruitingResearchers are testing AMP-101, an experimental gene therapy, in people with DOK7 congenital myasthenic syndrome, a rare inherited disorder that causes muscle weakness and exercise intolerance. About 4 participants with moderate to severe DOK7 CMS will receive a single intraveno…
Phase 1 • Sponsor: Amplo Biotechnology • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Gene therapy aims to free type 1 diabetics from insulin shots
Cure Not yet recruitingResearchers are testing two experimental gene therapies, VV-14299 and VV-14300, in adults with long-standing type 1 diabetes whose blood sugar remains poorly controlled despite using an automated insulin pump. The therapies are injected into muscle and are designed to work togeth…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Laser zaps pilonidal sinus in minimally invasive procedure
Cure Not yet recruitingResearchers are testing a minimally invasive laser procedure to treat chronic pilonidal sinus, a painful condition near the tailbone. The trial enrolls adults with sinus tracts between 2 and 9 centimeters, excluding those with acute abscesses or prior surgery. During the procedur…
Sponsor: State Scientific Centre of Coloproctology, Russian Federation • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Stem cells through the nose: a shot at stopping cerebral palsy
Cure Not yet recruitingNewborns who suffer a stroke or oxygen loss around birth can develop cerebral palsy and other lifelong disabilities, and no treatment can repair the damage. Researchers at UMC Utrecht are testing whether a single dose of bone marrow-derived mesenchymal stromal cells, sprayed into…
Phase 2/3 • Sponsor: UMC Utrecht • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
Cure Not yet recruitingResearchers are testing a gene therapy called VV-14300 in adults with long-standing type 1 diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system. The therapy uses a harmless virus to deliver the glucokinase gene into muscle, where…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
A Patient's own immune cells, grown in the lab, tested against advanced lung cancer
Cure Not yet recruitingResearchers are testing an experimental cell therapy called HS-IT101 in people with advanced non-small cell lung cancer. The treatment uses tumor-infiltrating lymphocytes (TILs), immune cells taken from the patient's own tumor, multiplied in the lab, and given back. Before receiv…
Phase 1 • Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Can a Patient's own immune cells fight back against recurrent brain cancer?
Cure Not yet recruitingResearchers are testing CHANK-101, a therapy made from a patient's own natural killer (NK) cells, in adults with glioblastoma that has returned after standard treatment. The study enrolls 60 participants who receive intravenous infusions of these cells every two weeks for up to 1…
Sponsor: Dong-A University Hospital • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Experimental therapy SNC116 put to the test against Hard-to-Treat leukemia
Cure Not yet recruitingResearchers are testing an experimental therapy called SNC116 in adults with B-cell acute lymphoblastic leukemia that has returned or stopped responding to treatment. The early-stage study enrolls about 28 people and focuses on safety, side effects, and how the body processes the…
Early phase 1 • Sponsor: Shanghai Simnova Biotechnology Co.,Ltd. • Aim: Cure
Last updated Sep 21, 2026 21:00 UTC
-
Experimental therapy aims to turn brain tumors against themselves
Cure Not yet recruitingResearchers are testing an experimental therapy called SRN-101 in adults with recurrent high-grade glioma, an aggressive brain cancer that has returned after standard treatment. Participants receive SRN-101 directly into the tumor before planned surgery to remove it. The trial's …
Phase 1 • Sponsor: Nicholas Butowski • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
One small incision vs several: robotic stomach cancer surgery put to the test
Cure Not yet recruitingResearchers are comparing two ways of performing robotic surgery to remove stomach cancer: a single-port approach and a standard multi-port approach. The trial enrolls 212 adults with stomach cancer that can be removed with distal gastrectomy. The main question is whether the sin…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can immunotherapy before surgery stop early oral cancer from returning?
Cure Not yet recruitingThis phase 3 trial tests whether adding sintilimab, an immunotherapy drug, to chemotherapy before surgery helps people with early-stage oral squamous cell carcinoma. Participants are adults aged 18 to 75 with cT2N0M0 oral cancer that can be removed by surgery. Half receive sintil…
Phase 3 • Sponsor: caohaotian • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can feeding allergens to toddlers build lasting food allergy tolerance?
Cure Not yet recruitingResearchers test whether daily oral immunotherapy can safely treat food allergy in children aged 0 to 2 with peanut, tree nut, or sesame allergy. Half the children receive the therapy, starting with tiny amounts of the allergen and building up over about six months, then a year o…
Sponsor: Copenhagen Studies on Asthma in Childhood • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Dengue vaccine takes on a controlled virus challenge
Vaccine Not yet recruitingResearchers are testing a new dengue vaccine called VLPDEN-02 in 42 healthy adults who have never had a flavivirus infection. The vaccine combines four virus-like particles, one for each dengue virus type, with an adjuvant to boost the immune response. Participants receive three …
Phase 1 • Sponsor: VLP Therapeutics • Aim: Vaccine
Last updated Sep 21, 2026 21:00 UTC
-
Malaria vaccines put to the test: can three new shots trigger protection?
Vaccine Not yet recruitingResearchers are testing three experimental malaria vaccines (LYB014, LYB017, and LYB027) in healthy adults aged 18 to 50. Participants receive either a low or high dose of one vaccine combined with an immune-boosting adjuvant, or the adjuvant alone as a comparison. The trial trac…
Phase 1 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: Vaccine
Last updated Sep 21, 2026 21:00 UTC
-
Could a vaccine shield HIV-Exposed newborns? early trial launches
Vaccine Not yet recruitingThis early-stage trial will test a new HIV vaccine in 22 infants who were exposed to HIV during birth but are not infected. The vaccine is designed to train the immune system to recognize and fight HIV. The main goal is to see if the vaccine is safe and whether it triggers an imm…
Phase 1 • Sponsor: HIV Vaccine Trials Network • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Nasal spray vaccine aims to stop COVID-19 at the source
Vaccine Not yet recruitingThis study tests a new type of COVID-19 booster vaccine given as a nasal spray. The vaccine uses a weakened live virus to train the immune system, potentially offering stronger protection in the nose and throat where the virus enters. Researchers are enrolling 80 healthy adults a…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Could a vaccine clear up severe teen acne?
Vaccine Not yet recruitingThis trial is testing whether an experimental mRNA vaccine can safely reduce moderate-to-severe acne in adolescents aged 12 to 17. Participants receive either the vaccine at different dose levels or a placebo, and researchers monitor safety and changes in facial acne lesions. The…
Phase 2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New mRNA vaccine aims to outsmart flu by targeting its hidden parts
Vaccine Not yet recruitingThis Phase 1 trial tests experimental mRNA vaccines designed to protect against many types of influenza A by targeting a stable part of the virus. Healthy adults aged 18 to 59 receive one or two doses of the vaccine candidates, alone or in combination. The study checks for side e…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Bispecific antibody combo aims to deepen myeloma responses
Disease control Not yet recruitingResearchers are testing whether CM336, a bispecific antibody that helps the immune system target myeloma cells, works safely and effectively when combined with daratumumab and lenalidomide. The trial enrolls adults aged 18 to 75 with newly diagnosed multiple myeloma who are not p…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a faster radiation course match the standard one after breast reconstruction?
Disease control Not yet recruitingResearchers compare two radiotherapy schedules for women who had breast reconstruction after mastectomy for breast cancer. One schedule gives larger daily doses over 3 weeks; the other gives smaller daily doses over 5 weeks. The trial checks whether the shorter schedule controls …
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Pig liver trial offers temporary lifeline for liver failure patients
Disease control Not yet recruitingThis early-stage study tests a genetically-modified pig liver used outside the body to temporarily take over liver functions for people with acute-on-chronic liver failure. About 20 adults who are not eligible for a transplant will receive this treatment for a short time. The goa…
Phase 1/2 • Sponsor: eGenesis, INC • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can dentists patch a failing baby tooth instead of drilling it out?
Disease control Not yet recruitingDentists often replace a failed filling in a baby tooth by drilling it out and starting over. This trial tests a gentler option: repairing just the broken part and leaving the healthy filling in place. Researchers will assign 824 baby molars from children aged 4 to 8 to either re…
Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can an app plus nicotine gum help hispanic smokers kick the habit?
Disease control Not yet recruitingThis phase III trial will enroll 854 Hispanic adults who smoke and want to quit. Participants will use the iCanQuit smartphone app, which teaches skills to manage cravings and prevent relapse. Half will also receive nicotine replacement therapy (gum, patch, or lozenge) to ease wi…
Phase 3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Experimental drug duo aims to boost immune attack on tough cancers
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, obrixtamig and ZL-1310, designed to help the immune system fight cancer. It is for adults with advanced small cell lung cancer or other neuroendocrine cancers. The trial has two parts: the first finds a safe dose of the tw…
Phase 1/2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Surgeons could freeze lung tumors from miles away using 5G robots
Disease control Not yet recruitingResearchers are testing whether a doctor can remotely steer a robotic bronchoscope over a 5G network to freeze small lung tumors from inside the airway. The study enrolls about 15 adults with non-small cell lung cancer or controlled metastatic lung tumors, each no larger than 3 c…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests whether adjusting chemotherapy doses for each patient can improve outcomes after a stem cell transplant for blood cancers caused by a RUNX1 gene mutation. Up to 98 people aged 4 to 70 with these cancers will receive a transplant from a half-matched donor. The goa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New pill aims to outsmart resistant prostate cancer
Disease control Not yet recruitingResearchers are testing a new oral drug called JNJ-101556143 in people with metastatic prostate cancer that has stopped responding to hormone therapy. The trial aims to see if the drug can shrink tumors or make them disappear. About 100 participants will receive the drug, and doc…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New drug takes aim at Hard-to-Treat squamous lung cancer
Disease control Not yet recruitingResearchers are testing an experimental drug called 7MW3711 against the standard chemotherapy docetaxel in people with locally advanced or metastatic squamous non-small cell lung cancer. All participants have already received platinum-based chemotherapy and immunotherapy, and the…
Phase 3 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a new antibody help when thyroid eye disease comes back?
Disease control Not yet recruitingResearchers are testing veligrotug, an intravenous antibody, in adults with moderate to severe thyroid eye disease that returned after they responded to teprotumumab. The trial enrolls about 30 participants who completed a full course of teprotumumab at least nine months earlier …
Phase 4 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
Disease control Not yet recruitingThis phase 1 trial is testing an experimental drug called ATG-201 in adults with systemic lupus erythematosus, systemic sclerosis, or Sjögren's disease. ATG-201 is designed to bind to specific proteins on immune cells, potentially quieting the overactive immune response that driv…
Phase 1 • Sponsor: Antengene Biologics Limited • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Two-Drug combo tested against aggressive pancreatic cancer
Disease control Not yet recruitingResearchers are testing whether combining albumin-bound paclitaxel with gemcitabine helps people with metastatic pancreatic cancer who have not yet received systemic treatment. The study enrolls about 59 adults aged 18 to 75 with confirmed metastatic pancreatic adenocarcinoma. Pa…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Triple drug combo targets myeloma that came back
Disease control Not yet recruitingResearchers are testing a combination of three drugs, belantamab mafodotin, cevostamab, and pomalidomide, in adults whose multiple myeloma has returned after at least two prior treatments. The phase 1b trial aims to find the best dose and see how well the combination controls the…
Phase 1 • Sponsor: Canadian Myeloma Research Group • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a sugary drink before surgery steady blood sugar in diabetes?
Disease control Not yet recruitingResearchers are testing whether a carbohydrate drink before gastrointestinal surgery can reduce insulin resistance and improve blood sugar stability in adults with type 2 diabetes. Participants are randomly assigned to one of three groups: standard fasting without a carb drink, a…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New antibody drug zuberitamab takes aim at kidney disease in phase 3 trial
Disease control Not yet recruitingResearchers are testing an experimental antibody drug called zuberitamab in people with primary membranous nephropathy, a kidney condition that causes protein to leak into the urine. The trial compares zuberitamab injections with cyclosporine, a standard immune-suppressing drug, …
Phase 3 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Engineered immune cells take aim at stubborn solid tumors
Disease control Not yet recruitingThis trial tests a new approach for people with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own myeloid cells, a type of immune cell, which are genetically modified in a lab to produce a cancer-fighting protein called IL…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a simple bottle help turn the tide on HIV?
Disease control Not yet recruitingThis trial tests whether B-OK bottles, which use beads to visually explain how HIV affects health and how treatment lowers viral load, can help people with HIV stick to their medication. Researchers will roll out the bottles across HIV case management agencies in Philadelphia and…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New antibody RC148 takes aim at lung cancer in Head-to-Head phase 3 trial
Disease control Not yet recruitingResearchers are testing whether adding the experimental drug RC148 to platinum-based chemotherapy helps people with advanced non-squamous non-small cell lung cancer live longer without their disease worsening, compared with tislelizumab plus the same chemotherapy. The trial enrol…
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a catheter slice thick heart muscle without open surgery?
Disease control Not yet recruitingThis study tests a minimally invasive procedure called SESAME for people with thickened heart muscle that blocks blood flow from the heart. The procedure uses a catheter to make a controlled slice in the muscle, aiming to relieve symptoms like shortness of breath. Researchers wil…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Smartphone app may boost parenting skills for child outbursts
Disease control Not yet recruitingThis trial tests whether a smartphone app can enhance parent management training (PMT) for children aged 8 to 13 with disruptive behavior disorders, such as conduct disorder or ADHD. Parents receive 12 weekly PMT sessions, and half also use a digital tool with videos, a resource …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a WhatsApp diabetes coach in urdu help control blood sugar?
Disease control Not yet recruitingResearchers are testing UrDiaCare, an Urdu-language app that gives diabetes self-management education and support through WhatsApp or Android. The trial includes 406 adults aged 30 to 70 in Pakistan who have type 2 diabetes and higher-than-recommended blood sugar levels. Particip…
Sponsor: National University of Medical Sciences, Pakistan • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Texts and calls put to the test to keep heart failure patients on their meds
Disease control Not yet recruitingKaiser Permanente researchers are testing whether digital outreach helps adults with heart failure refill medications they have let lapse. Participants are assigned to receive either interactive text messages or automated phone calls encouraging refills, or usual care with no ext…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a One-Week radiation course match four weeks for prostate cancer?
Disease control Not yet recruitingResearchers are testing whether a five-fraction course of stereotactic body radiotherapy (SBRT) works as well as the standard 20-fraction radiotherapy for men who need radiation after prostate cancer surgery. The trial enrolls 206 adults and randomly assigns them to either the sh…
Phase 3 • Sponsor: Robert Förster • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can targeted drugs boost surgery success in Hard-to-Treat lung cancer?
Disease control Not yet recruitingResearchers are testing whether giving targeted therapy before and after surgery helps people with stage III non-small cell lung cancer that has specific rare gene changes. The study includes 190 adults whose tumors have alterations in genes like EGFR, ALK, ROS1, MET, RET, or KRA…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can you keep the weight off after stopping GLP-1 drugs? scientists test three exit plans
Disease control Not yet recruitingMany people who lose weight with GLP-1 drugs like semaglutide or tirzepatide face a choice: stay on the drug indefinitely or stop and risk regaining the weight. This pilot trial compares three approaches in 60 adults with obesity who have reached or nearly reached their target we…
Phase 4 • Sponsor: Jing Luo • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Antibiotics after abscess drainage may block painful fistula formation
Disease control Not yet recruitingThis trial tests whether a 7-day course of antibiotics after draining a first-time perianal abscess can stop an anal fistula from forming. Adults with a first abscess are randomly assigned to receive antibiotics or not, then followed for up to 12 months. The goal is to see if ant…
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can an unapproved device change how we manage this condition?
Disease control Not yet recruitingThis trial tests a medical device that has not been approved or cleared by the U.S. FDA. Researchers want to learn whether the device is safe and whether it can help people with a specific condition. Participants receive the device as part of the study, and the team monitors thei…
Phase 4 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New drug aims to tame rare nerve disease
Disease control Not yet recruitingThis trial tests a drug called ripertamab in people with neuromyelitis optica spectrum disorder (NMOSD), a rare condition where the immune system attacks the optic nerves and spinal cord. Participants receive the drug by IV infusion four times over 73 weeks and are monitored for …
Phase 1/2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Triple drug combo targets advanced liver cancer in new trial
Disease control Not yet recruitingResearchers are testing a drug combination for people with advanced hepatocellular carcinoma, a type of liver cancer that cannot be removed by surgery. Participants receive lenvatinib plus tislelizumab, and some also receive gefitinib. The trial compares how long people live with…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a targeted drug keep ovarian cancer at bay longer?
Disease control Not yet recruitingThis trial is testing whether a targeted therapy called raludotatug deruxtecan (R-DXd), given alone or with bevacizumab, can help people with newly diagnosed advanced ovarian cancer live longer without their cancer growing. Participants have already completed first-line platinum-…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Four drugs aimed at a leukemia that turns aggressive
Disease control Not yet recruitingResearchers are testing whether a combination of rituximab, pirtobrutinib, lisaftoclax and liposomal mitoxantrone can shrink tumors in adults whose chronic lymphocytic leukemia has transformed into the aggressive cancer Richter syndrome. The trial plans to enroll 23 adults who wi…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can an existing drug boost bevacizumab against recurrent brain cancer?
Disease control Not yet recruitingResearchers are testing whether adding entacapone to bevacizumab is safe and can slow tumor growth in adults with glioblastoma that has returned after standard treatment. The trial enrolls about 96 participants who have not previously received bevacizumab and for whom repeat surg…
Phase 1/2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Could a special supplement boost health in cystic fibrosis?
Disease control Not yet recruitingThis study will test whether a nutrition supplement with different forms of certain nutrients works better than standard supplements for adults with cystic fibrosis. Sixty participants will take the supplement for six weeks, and researchers will measure nutrient levels in their b…
Sponsor: Ohio State University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a single psilocybin dose help break meth addiction?
Disease control Not yet recruitingThis trial investigates whether a single dose of psilocybin, given during a supervised session and paired with brief cognitive behavioral therapy, can help adults with moderate to severe methamphetamine use disorder reduce or stop their use. Participants receive one of two dose l…
Phase 2 • Sponsor: Peter Hendricks • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a daily pill shield hearts in HFpEF?
Disease control Not yet recruitingResearchers are testing whether adding finerenone to standard heart failure care can protect heart function and prevent worsening heart failure in people with heart failure with preserved ejection fraction (HFpEF). The trial enrolls adults with HFpEF who are randomly assigned to …
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can two existing drugs stop rheumatic fever from scarring young hearts?
Disease control Not yet recruitingResearchers are running a Phase 3 trial to see whether hydroxychloroquine or corticosteroids can reduce heart valve damage in children and young people with acute rheumatic fever. The trial enrolls about 600 participants aged 4 to 25 who are hospitalized with confirmed valve infl…
Phase 3 • Sponsor: Starship Child Health, Te Toka Tumai Auckland • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a new pill slow Alzheimer's decline?
Disease control Not yet recruitingThis trial tests whether an experimental drug called RO7568282 can slow the progression of early Alzheimer's disease. About 450 people with mild cognitive impairment or mild dementia due to Alzheimer's will receive either the drug or a placebo for 72 weeks. Researchers will measu…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a lab-made antibody stop bleeding in a rare blood disorder?
Disease control Not yet recruitingResearchers are testing denecimig, an experimental antibody given as an injection under the skin, in adults newly diagnosed with acquired haemophilia A. This rare condition causes the immune system to attack a clotting protein, leading to sudden and sometimes severe bleeding. The…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a new pill slow Parkinson's motor decline?
Disease control Not yet recruitingThis phase 2 trial is testing whether an experimental drug called RO7568282 can slow the worsening of motor symptoms in people with early-stage Parkinson's disease. Participants, aged 40 to 85, must be on stable levodopa monotherapy. The study compares the drug against a placebo …
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Engineered immune cells take aim at stubborn blood disorder
Disease control Not yet recruitingThis early-phase trial tests a new therapy called META 10-19 for people with autoimmune hemolytic anemia (AIHA) that has not responded to standard treatments. AIHA is a condition where the immune system mistakenly destroys red blood cells, causing anemia. META 10-19 uses a patien…
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a liver drug help patients with fatty liver disease and a stiff heart?
Disease control Not yet recruitingResearchers are testing resmetirom, an oral drug, in adults who have metabolic dysfunction-associated steatohepatitis (MASH) and heart failure with preserved ejection fraction (HFpEF). The trial assigns participants to receive resmetirom or a placebo for 24 weeks. The main goals …
Phase 1 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Targeted antibody zolbetuximab tested with chemo against advanced stomach cancer
Disease control Not yet recruitingResearchers are testing whether adding zolbetuximab to standard chemotherapy is safe and helps control advanced stomach or gastroesophageal junction cancer in Indian patients. The trial enrolls 50 adults whose tumors carry the Claudin 18.2 protein but not HER2. Participants recei…
Phase 4 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Liver tumors targeted directly: old pump, new drug
Disease control Not yet recruitingThis trial tests whether a drug called carfilzomib, given directly to the liver through an implanted pump, is safe for people whose colon, adrenal, or bile duct cancer has spread to the liver and persists after prior pump therapy. Participants receive weekly infusions of the drug…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New team approach aims to simplify care for heart and kidney health
Disease control Not yet recruitingThis study tests a 6-month program where patients work with a pharmacist and their primary care doctor to make shared decisions about medications and lifestyle. The goal is to see if this team-based approach improves heart and kidney health scores and medication adherence. The st…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Experimental drug targets Hard-to-Treat leukemia in small early trial
Disease control Not yet recruitingThis early study tests an experimental drug called zeprumetostat in people with a rare type of leukemia (T-cell large granular lymphocyte leukemia) that has not responded to or has come back after other treatments. Ten participants take the drug twice daily for two 28-day cycles.…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a diabetes and Weight-Loss drug help people quit meth?
Disease control Not yet recruitingResearchers at UT Southwestern Medical Center are testing whether tirzepatide, a drug approved for diabetes and weight loss, can help people with moderate to severe methamphetamine use disorder reduce or stop using the drug. The trial enrolls 228 adults aged 18 to 65 who are over…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.
Disease control Not yet recruitingThis trial is investigating whether ATH434, an experimental drug taken twice daily as a tablet, can help control multiple system atrophy (MSA), a rare and progressive brain disorder. The study enrolls people who have already completed a prior phase 2 trial of ATH434 and may benef…
Phase 2 • Sponsor: Alterity Therapeutics • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Could a supplement and drug combo help treat obesity?
Disease control Not yet recruitingThis Phase 2 trial tests whether combining the supplement alpha-lipoic acid with the drug mirabegron can improve how the body processes sugar in people with obesity. Sixty adults aged 18 to 65 with a BMI between 30 and 45 will take the combination or a placebo for 4 weeks. The st…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a biosimilar match vectibix in colorectal cancer treatment?
Disease control Not yet recruitingResearchers are testing whether QL1203, a proposed biosimilar of the drug Vectibix (panitumumab), behaves similarly in the body to the original Vectibix when both are combined with chemotherapy (mFOLFOX6). The trial enrolls adults with RAS wild-type metastatic colorectal cancer t…
Phase 1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New injectable drug tested for safety in Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a phase 1 trial of SHR-4595, an experimental injectable drug, in adults with advanced solid tumors that have not responded to standard treatments. The study checks how safe and tolerable the drug is, how the body processes it, and what dose might work best…
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a vaccine plus a Blood-Vessel blocker stop airway growths from coming back?
Disease control Not yet recruitingThis phase II trial tests whether combining bevacizumab, a drug that limits blood vessel growth, with PRGN-2012, a vaccine-based therapy, can help adults with recurrent respiratory papillomatosis (RRP) avoid needing more surgeries. RRP causes wart-like growths in the airway that …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Oral Brain-Penetrating drug tested against aggressive IDH1-Mutant gliomas
Disease control Not yet recruitingResearchers are testing an oral drug called safusidenib in adults newly diagnosed with IDH1-mutant grade 3 oligodendroglioma or astrocytoma, two types of brain tumor. Safusidenib is designed to cross into the brain and block the mutated IDH1 enzyme that drives these tumors. All 2…
Phase 2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingThis study tests two new ways to treat talaromycosis, a serious fungal infection in people with HIV. It compares a single high dose of a newer antifungal drug (liposomal amphotericin B) against two weeks of the standard drug, and also checks if adding another medicine (flucytosin…
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a simple checklist cut unnecessary antibiotics for diverticulitis?
Disease control Not yet recruitingAcute uncomplicated diverticulitis is often treated with antibiotics, but evidence suggests they are not always needed. This study evaluates whether a standardized treatment approach based on clinical findings, lab results, other health conditions, and CT scans can reduce unneces…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Triple oral drug combo targets two stubborn gynecologic cancers
Disease control Not yet recruitingResearchers are testing a combination of three oral drugs, imlunestrant, abemaciclib, and selinexor, in people with low grade serous ovarian cancer or endometrioid endometrial cancer. The trial enrolls 60 participants in two separate groups, one for each cancer type. Everyone rec…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Freezing tumors plus dual immunotherapy: a new attack on bile duct cancer
Disease control Not yet recruitingResearchers are testing whether adding cryoablation, a procedure that freezes tumors, to two drugs can help people with advanced biliary tract cancer that worsened after first-line treatment. The drugs are QL1706, a dual immunotherapy, and lenvatinib, a targeted therapy. The tria…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Stroke recovery goes home: robot hand trainer could boost therapy without a therapist
Disease control Not yet recruitingThis study tests whether stroke survivors can safely use a robot called ReHandyBot to exercise their hand at home without a therapist present. Participants first learn how to use the device at a clinic, then take it home to train on their own. The goal is to see if unsupervised h…
Sponsor: Swiss Federal Institute of Technology • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Targeted drug conjugate CBX-12 tested against childhood sarcomas
Disease control Not yet recruitingResearchers are testing a drug called CBX-12 in children and young adults with solid tumors that have returned or stopped responding to treatment, including rhabdomyosarcoma and Ewing sarcoma. CBX-12 pairs a tumor-seeking peptide with exatecan, a chemotherapy drug that blocks can…
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Could a diabetes drug help people stop using cannabis?
Disease control Not yet recruitingThis study tests a medicine called tirzepatide to see if it can help people with moderate to severe cannabis use disorder use less cannabis or stop altogether. One hundred adults aged 18 to 70 will receive either the drug or a placebo, and researchers will track their cannabis us…
Phase 2 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
40 weeks or 41? the delivery timing question for gestational diabetes
Disease control Not yet recruitingResearchers are testing whether waiting until 41 weeks to induce labor leads to fewer cesarean deliveries than inducing at 40 weeks in first-time mothers with diet-controlled gestational diabetes. The trial enrolls 1,500 women who manage their blood sugar through diet and exercis…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Balloon treatment tested against drugs for stroke risk from narrowed brain arteries
Disease control Not yet recruitingResearchers are comparing a drug-coated balloon procedure plus intensive medical care against intensive medical care alone in people with severely narrowed brain arteries that have caused stroke or mini-stroke symptoms. The trial enrolls 570 adults aged 18 to 80. Everyone receive…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can two drugs plus chemoradiation let bladder cancer patients keep their bladder?
Disease control Not yet recruitingResearchers are testing whether adding sacituzumab tirumotecan and subcutaneous pembrolizumab to chemoradiotherapy helps people with muscle-invasive bladder cancer live longer without the cancer growing or returning. The trial enrolls about 400 people who have chosen bladder pres…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a Platelet-Boosting drug speed recovery after stem cell transplant?
Disease control Not yet recruitingAfter an allogeneic stem cell transplant, patients often face weeks with dangerously low platelets and need frequent transfusions. This trial tests whether romiplostim, a drug that stimulates platelet production, helps platelets recover faster. Researchers randomly assign 87 adul…
Phase 2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New quadruple therapy targets liver cancer and diabetes together
Disease control Not yet recruitingThis study tests a combination of four drugs (epalrestat, HAIC, donafenib, and tislelizumab) as a first treatment for people with advanced liver cancer that cannot be removed by surgery and who also have diabetes. The goal is to see if this approach can control the cancer for at …
Phase 2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Diabetes drug dapagliflozin takes on metformin in PCOS hormone battle
Disease control Not yet recruitingResearchers compare dapagliflozin, a diabetes drug, with metformin, the standard insulin-sensitizing treatment, in women with polycystic ovary syndrome. The trial enrolls 70 women aged 18 to 40 who have PCOS and infertility. Over the study, the team measures changes in follicle-s…
Phase 2/3 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a daily pill protect kidneys in IgA nephropathy? MRI study puts atrasentan to the test
Disease control Not yet recruitingResearchers are testing whether adding atrasentan to standard supportive care improves kidney structure and function in adults with IgA nephropathy, a condition where the immune system damages the kidneys. About 20 participants will take atrasentan 0.75 mg once daily for 52 weeks…
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a simple alert get more ER patients with opioid addiction the right medication?
Disease control Not yet recruitingResearchers at Yale are testing a decision-support tool called EMBED CDS that alerts emergency department doctors when a patient with opioid use disorder might be eligible for buprenorphine, a medication that eases withdrawal and cravings. The study involves 100 adults with moder…
Sponsor: Yale University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New hope for hair loss: vitamin d cream vs steroid shots
Disease control Not yet recruitingThis study tests whether a vitamin D-based cream (calcipotriol) works as well as steroid injections for regrowing hair in people with patchy alopecia areata. Sixty adults with less than half their scalp affected will use one of the two treatments for 12 weeks. The goal is to see …
Phase 4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a new pill outsmart Drug-Resistant leukemia?
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called nemtabrutinib in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has stopped responding to other targeted therapies. Participants take nemtabrutinib once daily in 28-day cycles until the …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Brain pacemaker trial aims to quiet voices in Treatment-Resistant schizophrenia
Disease control Not yet recruitingThis pilot study will test whether deep brain stimulation (DBS) can help people with schizophrenia who still hear voices and have delusions despite trying multiple medications. Fifteen adults will have electrodes placed in a brain region linked to schizophrenia symptoms. The goal…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a new drug cool the hidden inflammation that fuels heart disease?
Disease control Not yet recruitingResearchers are testing an experimental drug called YMI024 in adults with stable coronary artery disease and high levels of a blood marker of inflammation called hsCRP. The trial assigns about 180 participants to one of five doses of YMI024 or a placebo, with neither participants…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New pill may boost insulin pump performance in type 1 diabetes
Disease control Not yet recruitingThis study tests an experimental pill (cadisegliatin) taken alongside insulin in people with type 1 diabetes who already use a hybrid closed-loop insulin pump. The goal is to see if the pill helps keep blood sugar in a healthy range more consistently. About 40 adults will receive…
Phase 2 • Sponsor: vTv Therapeutics • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Hope for sanfilippo kids: Brain-Infused drug enters final testing
Disease control Not yet recruitingThis phase 3 trial tests a drug called tralesinidase alfa in 14 children aged 1-5 with Sanfilippo syndrome type B, a rare genetic disease that causes severe brain damage. The drug is given directly into the brain fluid to replace a missing enzyme. The goal is to see if it can slo…
Phase 3 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Radioactive drug targets Hard-to-Treat thyroid cancer
Disease control Not yet recruitingThis study tests a radioactive drug called 177Lu-DOTA-EB-TATE in 18 adults with a rare thyroid cancer (Hurthle cell) that has spread and not responded to standard radioactive iodine treatment. The drug is designed to seek out and attach to cancer cells. Participants will receive …
Phase 1/2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Can a checklist and heart monitor stop repeat strokes?
Disease control Not yet recruitingResearchers are testing whether an educational and implementation tool helps hospitals follow best-practice guidelines for preventing second strokes caused by heart conditions. The trial enrolls about 2,400 patients who have had an ischemic stroke or a transient ischemic attack. …
Sponsor: Luciano A. Sposato • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sparing the liver: targeted chemoembolization meets lenvatinib in liver cancer
Disease control Not yet recruitingResearchers are testing whether a liver-sparing form of chemoembolization, called partial TACE, can boost the anti-tumor effects of the drug lenvatinib in people with liver cancer that cannot be removed by surgery. The trial enrolls about 40 adults with hepatocellular carcinoma w…
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple attack on pancreatic tumors: can radiation and immunotherapy make inoperable cancer operable?
Disease control Not yet recruitingResearchers test whether a short course of targeted radiation followed by the immunotherapy drug adebrelimab and NALIRIFOX chemotherapy can shrink locally advanced pancreatic cancer enough to allow surgery. The trial enrolls 36 adults with previously untreated pancreatic ductal a…
Phase 2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive missile aims at stubborn kidney tumors
Disease control Not yet recruitingResearchers are testing a radiopharmaceutical called 161Tb-PSMA-1 in adults with metastatic clear cell renal cell carcinoma that has worsened after at least two prior treatments, including immunotherapy and drugs that block blood vessel growth. The trial has two parts: a dose-esc…
Phase 1 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Under-the-Skin MS drug: can a shot replace an IV drip?
Disease control Not yet recruitingResearchers are observing how satisfied people with relapsing-remitting multiple sclerosis are when they receive ocrelizumab as an injection under the skin instead of an intravenous infusion. The study follows about 1,800 participants across multiple countries for 12 months, incl…
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly injection melt fat hiding in the pancreas?
Disease control Not yet recruitingThis trial tests whether mazdutide, an experimental weekly injection, can reduce fat buildup in the pancreas of adults with overweight or obesity. About 194 participants will receive either mazdutide or a placebo, alongside standard lifestyle advice, for 48 weeks. Researchers wil…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a daily eye gel replace injections for wet AMD?
Disease control Not yet recruitingThis trial is testing an experimental eye gel called BETA-TT8 for people with wet age-related macular degeneration (AMD), a condition that causes rapid vision loss. The gel is applied to the eye up to three times daily for 12 weeks, and standard injections remain available if nee…
Phase 1/2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New diabetes pill rybelsus under Real-World safety check in korea
Disease control Not yet recruitingThis study looks at the safety and effectiveness of Rybelsus, a pill for type 2 diabetes, in everyday medical practice in Korea. About 600 adults will take the medicine as their doctor prescribes, and researchers will track side effects and blood sugar control for 26 weeks. The g…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental infusion slow muscle loss in FSHD?
Disease control Not yet recruitingThis trial tests an experimental drug called SFL-0821 in adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. Researchers give the drug by intravenous infusion, either once or multiple times, and compare it agains…
Phase 1/2 • Sponsor: Soufflé Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental pill help teenagers with vitiligo?
Disease control Not yet recruitingResearchers are testing an experimental oral drug called VC005 in teenagers aged 12 to 17 who have non-segmental vitiligo, a condition where patches of skin lose their color. The study measures how the drug moves through the body and checks for safety over up to 24 weeks of treat…
Phase 1/2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can text messages fight anemia? new trial tests digital nutrition for teens
Disease control Not yet recruitingThis study tests whether adding digital nutrition education—via SMS or group sessions—to daily micronutrient supplements can lower anemia rates in 1,200 adolescents aged 15-19 in Dar es Salaam, Tanzania. All participants get supplements and basic nutrition info; some also receive…
Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can colorectal surgery patients go home in two days?
Disease control Not yet recruitingResearchers are studying whether patients can safely leave the hospital within 48 hours after minimally invasive colorectal surgery. The trial follows 97 adults having elective laparoscopic or robotic surgery for benign or malignant disease. It checks how many meet predefined cli…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two-Drug combo targets stubborn KRAS lung cancer
Disease control Not yet recruitingResearchers are testing whether combining BL-B01D1, an experimental antibody-drug conjugate, with glecirasib, a targeted KRAS G12C inhibitor, can shrink tumors in adults with locally advanced or metastatic non-small cell lung cancer that carries a KRAS G12C mutation. The phase 2 …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug combo aims to deepen myeloma response before transplant
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called F182112 to isatuximab and lenalidomide is safe and can help people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The trial enrolls about 10 adults aged 18 to 70. Participants r…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Gene therapy shots aim to save legs from amputation in diabetes
Disease control Not yet recruitingResearchers are testing whether seltoplasmid, a gene therapy injected into the calf muscle, can improve outcomes for people with type 2 diabetes who have poor blood flow to the foot and a non-healing ulcer. All participants first undergo a standard procedure to restore blood flow…
Phase 4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a liposomal drug combo improve AML treatment for older adults?
Disease control Not yet recruitingResearchers are testing a three-drug regimen called VAM for older or unfit adults with newly diagnosed acute myeloid leukemia (AML). The regimen combines liposomal mitoxantrone, azacitidine, and venetoclax. The trial aims to find the safest and most tolerable dose of liposomal mi…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can rituximab infusions keep scleroderma lungs stable?
Disease control Not yet recruitingResearchers test whether rituximab helps maintain lung function in adults with systemic sclerosis and interstitial lung disease whose disease has stabilized after initial rituximab treatment. Participants receive rituximab or placebo infusions at months 0, 6, and 12. The main mea…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an injected biologic cut steroid Flare-Ups in a Tough-to-Treat asthma complication?
Disease control Not yet recruitingResearchers are studying depemokimab, an injected biologic drug, in adults aged 18 to 75 who have allergic bronchopulmonary aspergillosis (ABPA) along with severe eosinophilic asthma. The study tracks how many asthma attacks need systemic steroids and whether participants' qualit…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat adrenal tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug cocktail aims to reverse early heart disease
Disease control Not yet recruitingThis Phase 3 trial will test whether a combination of three cholesterol-lowering drugs—bempedoic acid, ezetimibe, and a high-intensity statin—can reduce and stabilize plaque buildup in the coronary arteries. The study enrolls 103 adults with coronary atherosclerosis who have neve…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can tighter blood pressure control in pregnancy prevent serious complications?
Disease control Not yet recruitingThis trial tests whether treating high blood pressure in pregnancy to a stricter target (below 140/90) is better than the usual approach (below 160/110) for women with gestational hypertension or preeclampsia without severe features. About 4,120 pregnant women will be randomly as…
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat scleroderma in landmark trial
Disease control Not yet recruitingThis study tests whether a one-time infusion of specially engineered immune cells (CAR T cells) can improve lung function and skin hardening better than current treatments for people with active systemic sclerosis, a rare autoimmune disease. About 92 adults with lung involvement …
Phase 3 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lab-Grown tumor organoids could pick the right bladder chemo
Disease control Not yet recruitingResearchers are testing whether drug testing in patient-derived organoids can guide chemotherapy for low-grade non-muscle invasive bladder cancer. Adults with primary or recurrent low-grade bladder cancer receive one of four chemo drugs, epirubicin, mitomycin C, gemcitabine, or d…
Phase 2 • Sponsor: Hospital Centre Biel/Bienne • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly shot help people who still struggle with weight after bariatric surgery?
Disease control Not yet recruitingMany people who have bariatric surgery do not lose as much weight as expected or regain it over time. This trial tests whether tirzepatide, a weekly injection that acts on two gut hormones, helps adults with obesity lose more weight after surgery. Participants receive either tirz…
Phase 3 • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can simple tummy time reshape a Preemie's head?
Disease control Not yet recruitingThis trial tests whether a daily routine of tummy time and careful positioning can help correct cranial asymmetry—a flattened head shape—in premature newborns. About 300 babies born before 37 weeks who are in the neonatal ICU or intermediate care unit will be split into two group…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Patient's own airway stem cells repair damaged lungs in COPD?
Disease control Not yet recruitingResearchers are testing REGEND001, a therapy made from a patient's own airway basal stem cells, to see if it can improve lung function in people with chronic obstructive pulmonary disease (COPD) and emphysema. The trial enrolls adults aged 40 to 75 with moderate to severe COPD. P…
Phase 3 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
No more finger pricks? new study tests wearable sensor for pregnancy diabetes
Disease control Not yet recruitingThis study tests whether a continuous glucose monitor (CGM) is better than standard finger-prick tests for managing blood sugar in 100 pregnant women with gestational diabetes. Participants will either wear a small sensor or continue finger-pricking. The goal is to see if CGM is …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a single infusion tame tough lupus?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called SNC116 in people with refractory systemic lupus erythematosus (SLE), a form of lupus that hasn't improved with standard treatments. The study aims to see if a single intravenous infusion of SNC116 is safe and tolerable…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple checklist help surgeons remove every last cancer cell?
Disease control Not yet recruitingResearchers are testing whether a shared checklist used during lung cancer surgery helps surgeons achieve cleaner, more complete tumor removal. The trial enrolls adults with early-stage non-small cell lung cancer who are scheduled for surgery. Half the participating hospitals use…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Alpelisib's Long-Term safety tracked in PIK3CA patients
Disease control Not yet recruitingThis study provides continued access to alpelisib for people who are already benefiting from it in a previous Novartis trial. It focuses on tracking long-term safety, including any side effects, in participants with PIK3CA-related overgrowth spectrum or certain breast cancers. Pa…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a scalp gel turn back male pattern baldness?
Disease control Not yet recruitingResearchers are testing an experimental topical gel called PP405 in men with androgenetic alopecia, the most common form of male pattern hair loss. The trial enrolls about 600 men aged 18 to 55 with moderate hair loss at the top of the scalp. Participants apply either the PP405 g…
Phase 2/3 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New chemo cocktail targets pancreatic cancer at every stage
Disease control Not yet recruitingResearchers are testing a chemotherapy combination built around albumin-bound paclitaxel (II) for people with pancreatic cancer. The study has three groups: one for advanced cancer that cannot be removed by surgery, one for cancer that may be removable and receives treatment befo…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Bacteria-Based immunotherapy targets pancreatic tumors in first human test
Disease control Not yet recruitingResearchers are testing a new immunotherapy called Lm-LLO-TT in adults with advanced pancreatic ductal adenocarcinoma that has already been treated with chemotherapy. Lm-LLO-TT uses a weakened form of Listeria bacteria engineered to carry a tetanus toxoid antigen, aiming to spark…
Phase 1 • Sponsor: Loki Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can probiotics make h. pylori antibiotics easier on the gut?
Disease control Not yet recruitingResearchers test whether Bacillus probiotics, given alongside standard four-drug antibiotics for H. pylori infection, reduce gut side effects and improve treatment tolerance. The trial enrolls 336 adults with H. pylori who receive either a single-strain probiotic, a multi-strain …
Sponsor: Anabio R&D • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
Disease control Not yet recruitingResearchers are testing a new biological therapy called BI 4060107 in adults with advanced solid tumors that cannot be removed by surgery. The trial is for people who have tried all available treatments and have no other options. The main goal is to find the highest dose that peo…
Phase 1 • Sponsor: AIMEDBIO • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
A pill instead of surgery? trial tests vepugratinib against Low-Grade bladder cancer
Disease control Not yet recruitingResearchers are testing whether an oral drug called vepugratinib can clear low-grade, intermediate-risk bladder cancer that has not invaded muscle, or low-grade upper tract urothelial cancer. The trial enrolls adults whose tumors carry a specific change in the FGFR3 gene. Partici…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Laser light may help heal the brain after injury
Disease control Not yet recruitingThis early study tests a new, noninvasive laser treatment called Nano-Pulsed Laser Therapy (NPLT) for people with moderate to severe traumatic brain injury (TBI). The goal is to see if the treatment is safe and can be given soon after injury. Researchers will also check if the la…
Phase 1 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Old antiparasitic drug joins chemo in pancreatic cancer fight
Disease control Not yet recruitingResearchers at the University of Oklahoma are testing whether adding pentamidine, an antiparasitic drug, to standard modified FOLFIRINOX chemotherapy is safe and helps shrink tumors in people with advanced or metastatic pancreatic cancer. Up to 30 adults with confirmed locally ad…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug shorten Guillain-Barré recovery?
Disease control Not yet recruitingThis trial tests whether efgartigimod, a drug that lowers harmful antibody levels, can improve recovery in people with Guillain-Barré syndrome (GBS), a rare nerve condition that can cause weakness and paralysis. Adults aged 18 to 70 with recent GBS onset will receive either efgar…
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Zapping resistant tumors: could radiation extend the life of current breast cancer therapy?
Disease control Not yet recruitingThis trial is for people with ER-positive, HER2-negative advanced breast cancer whose disease has started to grow in a few spots while on hormone therapy and a CDK4/6 inhibitor. It tests whether adding targeted radiation (SABR) to those spots allows patients to stay on their curr…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Dual immunotherapy plus chemo before surgery: a new way to shrink stomach tumors?
Disease control Not yet recruitingResearchers are testing whether combining an experimental dual immunotherapy drug called QL1706 with standard chemotherapy (docetaxel, oxaliplatin and S-1) before surgery can help patients with locally advanced gastric or gastroesophageal junction cancer. The study enrolls 34 adu…
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Which biologic works best first for ulcerative colitis? major trial aims to find out
Disease control Not yet recruitingThis study compares four different sequences of biologic drugs (infliximab, filgotinib, ustekinumab, and vedolizumab) in 240 adults with moderate to severe ulcerative colitis. The goal is to see which order of treatments works best to achieve and maintain remission without steroi…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Daily pill giredestrant put to the test for sticking with breast cancer treatment
Disease control Not yet recruitingResearchers are studying giredestrant, an experimental daily pill, in people with estrogen receptor-positive, HER2-negative early breast cancer. The trial enrolls about 1,500 participants, including some who switch to giredestrant after other treatments. It tracks how many people…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Oral drug VT3989 takes on chemo in mesothelioma survival test
Disease control Not yet recruitingResearchers are comparing an experimental oral drug called VT3989 with standard chemotherapy drugs gemcitabine or vinorelbine in adults with advanced epithelioid pleural mesothelioma. All participants have already received platinum-based chemotherapy and immunotherapy, and their …
Phase 3 • Sponsor: Vivace Therapeutics, Inc • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Daily pill takes aim at a rare brain disease that mimics Parkinson's
Disease control Not yet recruitingResearchers are testing an experimental oral drug called ONO-2808 in adults with the Parkinsonian subtype of multiple system atrophy (MSA-P), a rare and progressive brain disorder. The phase 3 trial enrolls about 486 people in the early stages of the disease, within five years of…
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new care pathway speed up advanced heart failure decisions?
Disease control Not yet recruitingResearchers are testing whether a standardized care pathway helps adults with advanced heart failure in Latin America complete a multidisciplinary evaluation and receive a documented treatment decision within 90 days. The trial includes 360 adults with acquired or structural hear…
Sponsor: CardioVision International Tech, S.A.S. de C.V. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gene therapy joins forces with chemo and immunotherapy to fight bladder cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding a gene therapy called nadofaragene firadenovec to standard chemotherapy and immunotherapy can improve outcomes for people with muscle invasive bladder cancer before they have their bladder removed. The gene therapy is placed directly into t…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can zapping liver and lung tumors boost treatment for nasopharyngeal cancer?
Disease control Not yet recruitingResearchers are testing whether adding CT-guided thermal ablation of liver or lung metastases to standard systemic therapy improves tumor response in people with nasopharyngeal carcinoma. The trial enrolls 138 adults whose primary tumor was cured but who later developed up to fiv…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug telaglenastat aims to lower lung blood pressure
Disease control Not yet recruitingThis study tests whether the drug telaglenastat, taken twice daily for 12 weeks, can safely lower blood pressure in the lungs and improve heart and lung function in adults with pulmonary hypertension. About 28 participants will receive the drug on top of their usual care. The mai…
Phase 1/2 • Sponsor: Chan, Stephen, MD, PhD • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingThis study tests an experimental drug called centhaquine in 80 adults with moderate to severe ARDS, a life-threatening lung condition. The drug is added to standard care to see if it improves oxygen levels and reduces deaths. Participants must be in the ICU and start treatment wi…
Phase 2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new antibody boost treatment for Hard-to-Treat HER2 breast cancer?
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called HLX22 to standard trastuzumab and chemotherapy helps people with locally advanced or metastatic HER2-positive breast cancer that has already been treated with a HER2 ADC. About 90 adults will receive either HLX22 …
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
First-in-Human biologic JUR-003 put to the test against metastatic prostate cancer
Disease control Not yet recruitingResearchers are running a first-in-human Phase 1 trial of JUR-003, an intravenous biologic, in adults with metastatic prostate cancer. The study has two parts: a dose-escalation phase to find the highest dose people can tolerate, and a dose-expansion phase to look at early anti-t…
Phase 1 • Sponsor: Juri Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can antibiotics dripped through the skull bone reach the brain better than IV drugs alone?
Disease control Not yet recruitingResearchers are testing a new way to deliver antibiotics to the brain in people with moderate to severe bacterial meningitis who are not improving on standard intravenous treatment. The approach combines standard IV antibiotics with a continuous infusion of three antibiotics (van…
Sponsor: yilong Wang • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two oral drugs join chemotherapy in a bid to shrink pancreatic tumors
Disease control Not yet recruitingResearchers are testing whether adding two oral drugs, avutometinib and defactinib, to standard chemotherapy (mFOLFIRINOX) is safe and can slow or shrink pancreatic ductal adenocarcinoma. The trial has two parts: one for people whose cancer has spread, and one for people whose ca…
Phase 1/2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injectable drug tested against Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a Phase I trial of HEC-921, an experimental drug given by intravenous infusion, in adults with advanced malignant solid tumors. The study first gives HEC-921 alone to find the highest dose people can tolerate, then tests it in combination with oxaliplatin,…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Stem cell infusions put to the test against a tough transplant complication
Disease control Not yet recruitingResearchers are testing whether infusions of bone marrow-derived mesenchymal stem cells, called MesenCell, are safe for adults with moderate or severe chronic graft-versus-host disease that has not responded to steroids and other standard treatments. The trial enrolls up to 20 pe…
Phase 1 • Sponsor: Pontifícia Universidade Católica do Paraná • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New 3D heart imaging could sharpen ablation precision
Disease control Not yet recruitingThis study tests a new imaging and guidance system called VERAFEYE that creates a 3D model of the heart to help doctors navigate during catheter ablation for atrial fibrillation. About 50 adults with paroxysmal or persistent atrial fibrillation will have their standard ablation p…
Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Device aims to build dialysis access from inside the blood vessels
Disease control Not yet recruitingPeople with end-stage kidney disease need a reliable blood vessel connection, called a fistula, for hemodialysis. This study tests a device called the ePATH System, which creates that connection from inside the blood vessels rather than through open surgery. Researchers will foll…
Sponsor: Pathfinder Medical • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can older women with breast cancer skip chemo? new trial tests CDK4/6 inhibitors
Disease control Not yet recruitingResearchers are testing whether women aged 65 and older with early-stage, lymph node-positive, ER+/HER2- breast cancer can safely skip chemotherapy. Participants receive CDK4/6 inhibitors, with or without endocrine therapy, after surgery. The trial tracks how many women remain fr…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New immunotherapy targets genetic flaw in rare childhood cancers
Disease control Not yet recruitingThis study tests a new immunotherapy designed to help the immune system recognize and attack cancer cells in people with high-risk Ewing sarcoma or desmoplastic small round cell tumor (DSRCT). The treatment targets a specific genetic change found only in these cancer cells, aimin…
Phase 1 • Sponsor: Rabi Hanna • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
FitBits and texts: a new way to help moms lower blood pressure after birth
Disease control Not yet recruitingThis study tests a program for new mothers who had high blood pressure during pregnancy. Participants wear a FitBit and receive weekly messages with personalized activity goals. The goal is to see if this approach increases daily steps and improves blood pressure, and whether mom…
Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Bile may hold the key to guiding targeted treatment for bile duct and gallbladder cancers
Diagnosis Not yet recruitingResearchers want to know whether leftover bile fluid can reveal genetic changes in tumors of people with advanced biliary tract cancer, such as bile duct or gallbladder cancer. Collecting tumor tissue for genetic testing can be difficult or risky in this cancer, so the study coll…
Sponsor: CHA University • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Can a Tumor's DNA reveal the best lymphoma treatment?
Diagnosis Not yet recruitingResearchers at M.D. Anderson Cancer Center are testing whether comprehensive genomic sequencing can identify specific subtypes of large B-cell lymphoma and provide information that may help guide treatment decisions. The trial enrolls about 60 adults with stage 3 or 4 diffuse lar…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
A simple angle on an ultrasound scan may reveal how deeply a placenta has invaded
Diagnosis Not yet recruitingPlacenta accreta spectrum happens when the placenta grows too deeply into the uterus, which can cause dangerous bleeding during delivery. Doctors struggle to predict how severe each case will be before surgery. This study measures a new ultrasound angle, the placenta-cervical int…
Sponsor: Necmettin Erbakan University • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
New PET tracer targets ACP3 to spot prostate cancer
Diagnosis Not yet recruitingResearchers are testing a new PET imaging agent called [68Ga]Ga-OncoACP3 that targets a protein called ACP3, which is found in prostate cancer cells. The study enrolls 50 men with suspected or confirmed high-risk prostate cancer, or suspected recurrence after treatment. Each part…
Phase 2 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
New eye test spots brain fog after cornea surgery
Diagnosis Not yet recruitingThis study checks if a special thinking test (MoCA Blind) can find memory or thinking problems after cornea surgery. It includes 200 adults with cornea disease who will take the test before and 90 days after surgery. The goal is to give doctors a better way to spot these issues i…
Sponsor: The S.N. Fyodorov Eye Microsurgery State Institution • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Can two blood markers catch sepsis before it turns deadly?
Diagnosis Not yet recruitingSepsis is hard to spot early because its first symptoms look like many other conditions. Researchers at emergency departments in Taiwan are studying whether two blood markers, presepsin and immature granulocytes, can help doctors tell sepsis apart from other causes of inflammatio…
Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Can AI help doctors hear hidden heart defects in children?
Diagnosis Not yet recruitingResearchers in Qinghai Province, China, are testing whether artificial intelligence can help primary care doctors spot congenital heart disease during school-based screening. Schools are randomly assigned to either standard listening with a stethoscope or listening plus AI analys…
Sponsor: Kun Sun • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Can AI make lung cancer scans easier to read?
Diagnosis Not yet recruitingResearchers are building an artificial intelligence system that analyzes chest CT images and offers decision support to doctors reading those scans for lung cancer. They use deidentified CT exams from routine care to develop and lock the AI models. In the prospective stage, about…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Revolutionary CT tech could replace invasive heart tests
Diagnosis Not yet recruitingThis study tests advanced CT scans to find dangerous blockages in heart arteries without needing to insert a tube into the heart. About 142 adults with moderate blockages will get two types of CT scans, and results will be compared to the standard invasive test. The goal is to se…
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Sep 21, 2026 21:00 UTC
-
Your phone as a stethoscope: can an app spot hidden heart valve disease?
Diagnosis Not yet recruitingResearchers are testing whether a smartphone app called Stethophone can help primary care doctors find moderate or severe aortic stenosis in adults aged 70 and older. The app turns a phone into a digital stethoscope and analyzes heart sounds for murmurs that may signal the condit…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can wireless monitors make ER vitals easier for autistic children?
Diagnosis Not yet recruitingAutistic children in the emergency department often miss full vital sign checks because standard equipment can be distressing. This pilot study randomizes 100 children aged 2 to 17 to have their heart rate, breathing, oxygen and temperature measured either with wireless wearable …
Sponsor: Hamilton Health Sciences Corporation • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Could a work health check catch diabetic eye damage before it steals sight?
Diagnosis Not yet recruitingMany people with diabetes skip regular eye exams, even though early treatment can prevent vision loss. This pilot study tests whether offering retinal photography during routine occupational health visits makes screening easier to access. Workers with diabetes attend one visit wh…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New PET tracer aims to light up hidden cancer targets
Diagnosis Not yet recruitingResearchers are testing a new PET/CT imaging tracer called [68Ga]-LY4257529 that targets a protein called GRPR, which some cancers make in large amounts. The study includes up to 60 adults with breast cancer or other tumors known or suspected to express GRPR, such as prostate, ov…
Early phase 1 • Sponsor: Jewish General Hospital • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive tracer aims to light up hidden lung scarring
Diagnosis Not yet recruitingResearchers at Mayo Clinic are testing an investigational radioactive tracer called 68Ga-FAPI-46 to see how it distributes in the lungs of people with interstitial lung disease. About 10 participants with a clinical diagnosis of ILD and lung abnormalities on a recent CT scan rece…
Phase 1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Blood test could spare Head-Injury patients a brain scan
Diagnosis Not yet recruitingResearchers are testing whether adding a brain-injury blood test to standard clinical guidelines can safely reduce the number of brain CT scans ordered for adults who come to the emergency department with a suspected head injury. The blood test measures two proteins, GFAP and UCH…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a blood test before pancreatic surgery predict a dangerous leak?
Diagnosis Not yet recruitingResearchers are studying whether immune markers in a blood sample taken before pancreatic cancer surgery can predict a serious complication called postoperative pancreatic fistula, where digestive fluids leak from the surgical connection. Adults scheduled for curative-intent panc…
Sponsor: Institut Paoli-Calmettes • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Could a handheld ultrasound help clinics spot heart failure sooner?
Diagnosis Not yet recruitingResearchers at Corewell Health West are testing whether medical assistants can use a handheld ultrasound device to estimate heart pumping function in people with new heart symptoms. The trial enrolls up to 100 adults at rural outpatient clinics who have not had a recent echocardi…
Sponsor: Corewell Health West • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can 'Queen Mothers' bring HIV testing to the doorstep?
Diagnosis Not yet recruitingResearchers are testing whether sex work managers, called queen mothers, can hand out and collect HIV self-tests and self-collected STI test kits at places where female sex workers meet and work in Lusaka. The study compares this peer-supported approach with the current standard …
Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a special MRI match CT for spotting knee bone damage?
Diagnosis Not yet recruitingResearchers at Assiut University are testing whether a specialized MRI technique called multi-echo fast field echo (mFFE) can detect cortical bone changes in knee osteoarthritis as accurately as CT scans. The study enrolls 80 adults aged 40 and older with suspected or confirmed k…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
App aims to catch a hidden radiotherapy side effect
Diagnosis Not yet recruitingRadiation pneumonitis is a lung inflammation that can appear weeks after radiotherapy for lung cancer, and patients may not link their symptoms to the earlier treatment. Researchers developed a smartphone app called PneumoCheck for patients to use at home, hoping it helps detect …
Sponsor: University Hospital Schleswig-Holstein • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
A 2.2 mm scope could spot cancerous tissue in minutes, not days
Diagnosis Not yet recruitingDoctors usually send colorectal tissue to a lab and wait days for results. This pilot study tests a miniaturized device called MULTISCOPE that uses light-based imaging to tell healthy tissue from cancerous tissue in real time. Researchers will examine 30 tissue samples removed du…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Heart attack delay may signal kidney risk after angioplasty
Diagnosis Not yet recruitingResearchers are studying whether the total time from heart attack symptom onset to balloon inflation during angioplasty helps predict contrast-induced nephropathy, a kidney complication that can occur after the procedure. The trial enrolls 400 adults with ST-segment elevation myo…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Mapping the DNA test that decides who gets PARP inhibitors
Diagnosis Not yet recruitingResearchers are reviewing medical records from about 1,125 women in Italy with newly diagnosed advanced high-grade epithelial ovarian cancer. The study focuses on how hospitals test tumors for homologous recombination deficiency (HRD), a DNA repair flaw that can make PARP inhibit…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI helps surgeons see brain tumors better during surgery
Diagnosis Not yet recruitingThis trial tests a new AI device that helps surgeons see brain tumors on ultrasound images during surgery. The AI highlights tumor tissue in real time, which may help remove more of the tumor while protecting healthy brain. The study involves 100 adults scheduled for brain tumor …
Phase 3 • Sponsor: Hospital del Rio Hortega • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
New blood test method for liver disease could make diagnosis easier
Diagnosis Not yet recruitingThis study checks if a simpler way to collect blood samples works as well as the standard method for the HepQuant DuO liver test. The test involves drinking a natural substance and taking blood samples 20 and 60 minutes later. Researchers will compare different blood collection t…
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Breath test aims to classify leukaemia in hours, not days
Diagnosis Not yet recruitingDoctors often wait days for genetic tests to classify acute myeloid leukaemia (AML) and guide treatment. This trial tests whether breath analysis can detect metabolic products from leukaemia and classify the disease faster. Participants give breath samples and extra blood tests d…
Sponsor: Jeremy Deuel • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a CBD-Based drug stop seizures before they start?
Prevention Not yet recruitingThis trial tests whether Epidiolex, a prescription CBD medication, can delay or prevent the first seizure in infants with Sturge-Weber syndrome, a rare condition that often leads to seizures and developmental challenges. The study enrolls babies aged 1 to 18 months who have brain…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Flu shot showdown: can anflu match vaxigrip in Moms-to-Be?
Prevention Not yet recruitingResearchers are testing whether Sinovac's Anflu flu vaccine produces a strong immune response in pregnant women compared with Sanofi's Vaxigrip. The trial enrolls 150 healthy pregnant women between 22 and 34 weeks of pregnancy. Each participant receives one dose of either vaccine…
Phase 4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can a walk down the hall keep older patients independent after hospital?
Prevention Not yet recruitingOlder adults who are hospitalized often lose the ability to do everyday tasks, a problem called hospital-associated disability. Researchers at Hvidovre University Hospital are studying physical activity during and after hospitalization in people aged 65 and older. Participants wi…
Sponsor: Hvidovre University Hospital • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can a stearic Acid-Rich diet improve blood vessel health?
Prevention Not yet recruitingResearchers are testing whether a diet high in stearic acid, a type of saturated fat found in cocoa butter, improves blood vessel function compared with a diet high in oleic acid, the main fat in olive and canola oils. The trial enrolls 40 overweight or obese adults aged 40 to 70…
Sponsor: Florida State University • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can an app help black teens stay HIV-Free? small study aims to find out
Prevention Not yet recruitingThis study will test a mobile app called HealthMPowerment designed to help Black adolescents and young adults in Alabama take PrEP, a daily pill that prevents HIV. Ten teens and their adult supporters will use the app for a few weeks, and researchers will check if it's easy and a…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can a short talk with your doctor lower dementia risk?
Prevention Not yet recruitingResearchers are testing whether primary care doctors can deliver a brief lifestyle intervention to older adults at risk of dementia. The trial enrolls 300 people aged 60 and older with elevated dementia risk scores. Doctors at community health centers provide the intervention, an…
Sponsor: Fujian Medical University • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can hunting, fishing, and gathering protect alaska native hearts?
Prevention Not yet recruitingResearchers are testing a community-led prevention program called Qungasvik-Healthy Hearts in three rural Alaska Native communities. The program adapts traditional Yup'ik practices such as hunting, gathering, and fishing to see whether they can reduce risk factors for heart and c…
Sponsor: University of Alaska Fairbanks • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Chilling the pancreatic duct opening: can ice water cut Post-ERCP pancreatitis?
Prevention Not yet recruitingPancreatitis is a painful inflammation of the pancreas that can happen after an ERCP procedure. Doctors often give rectal indomethacin around the time of ERCP to lower that risk, but it still occurs. This trial randomly assigns adults having ERCP to receive either rectal indometh…
Sponsor: Unity Health Toronto • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can a drug combo stop esophageal cancer from returning after surgery?
Prevention Not yet recruitingResearchers are testing whether giving an anti-PD-1 immunotherapy drug together with anlotinib after surgery can prevent or delay the return of esophageal squamous cell carcinoma. The trial enrolls adults aged 18 to 75 who had chemotherapy plus immunotherapy before surgery, then …
Phase 2 • Sponsor: Shanghai Chest Hospital • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
School-Based digital tool aims to curb childhood obesity in beijing
Prevention Not yet recruitingThis study tests a school-based weight management program using a WeChat digital platform to help children in Fangshan District, Beijing, avoid excessive weight gain. About 1,400 children in grades 2 and 3 will either receive the program (health classes, daily physical activity, …
Sponsor: Peking University • Aim: Prevention
Last updated Sep 21, 2026 21:00 UTC
-
Can a common steroid shield breast cancer patients from a dangerous drug side effect?
Prevention Not yet recruitingTrastuzumab deruxtecan (T-DXd) treats metastatic breast cancer but can cause interstitial lung disease (ILD), a form of lung inflammation that sometimes forces patients to stop treatment. Researchers are testing whether giving dexamethasone before each T-DXd infusion lowers the c…
Phase 3 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a mobile app plus a breast model teach women to fight cancer fatalism?
Prevention Not yet recruitingResearchers test a hybrid breast cancer education program for women aged 20 to 65 who visit an obstetrics and gynecology clinic. The program combines a face-to-face session using a breast model with four weeks of educational messages and reminders sent through a mobile app. The t…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a pharmacist chat group help stop HIV?
Prevention Not yet recruitingResearchers at the University of Washington are studying whether an online community of practice helps pharmacists learn to prescribe PrEP, a daily pill that prevents HIV. The study enrolls about 500 pharmacists and pharmacy staff across the United States whose pharmacies do not …
Sponsor: University of Washington • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Alzheimer's vaccine aims to clear amyloid before memory fades
Prevention Not yet recruitingResearchers are testing an experimental vaccine called AV-1959R in adults aged 55 to 80 who have amyloid buildup in the brain but no memory or thinking problems. The trial compares the vaccine with a placebo to see whether it is safe, triggers an immune response, and lowers brain…
Phase 2 • Sponsor: Institute for Molecular Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
One dose to block the flu: baloxavir put to the test in households
Prevention Not yet recruitingResearchers are testing whether a single dose of the antiviral drug baloxavir marboxil can stop influenza from spreading among people who live with someone who has the flu. The trial enrolls households in China where one person has confirmed influenza and up to five other members…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can text messages and small rewards stop drinking in pregnancy?
Prevention Not yet recruitingResearchers are testing a behavioral program that sends supportive text messages and offers small rewards to pregnant women who test positive for alcohol, tobacco, or cannabis use in South Africa. The program aims to reduce substance use during pregnancy and breastfeeding, which …
Phase 2 • Sponsor: Philadelphia College of Osteopathic Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Two common drugs put to the test against kidney stones caused by cosmetic paraffin injections
Prevention Not yet recruitingParaffin disease happens when people inject paraffin oil into muscle for cosmetic enlargement, causing chronic inflammation, high blood calcium, kidney stones, and kidney damage. Researchers are testing whether empagliflozin or losartan, two drugs already used for kidney protecti…
Phase 2/3 • Sponsor: Martin Blomberg Jensen • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a smart bracelet and app stop a second stroke?
Prevention Not yet recruitingResearchers are testing whether a digital program that combines a smart bracelet and a mobile app can help people who have had an ischemic stroke avoid another one. The study enrolls adults who recently had a stroke and also have high blood pressure and diabetes. Half receive usu…
Sponsor: Affiliated Hospital of Nantong University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
How long does RSV protection last in a Baby's nose?
Prevention Not yet recruitingClesrovimab is an FDA-approved antibody shot for infants under 8 months entering their first RSV season when their mothers did not get an RSV vaccine in pregnancy. Researchers at Emory University are measuring antibody levels in the blood and noses of 24 healthy infants who recei…
Phase 4 • Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingThis study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…
Phase 1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can an AI chatbot coach people away from type 2 diabetes?
Prevention Not yet recruitingResearchers are testing an AI chatbot that gives personalized, culturally tailored advice on nutrition, physical activity, and goal setting to adults at risk for type 2 diabetes. About 30 adults aged 18 to 55 will use the chatbot for 6 weeks. The study will check whether the chat…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
AI-Crafted care plan aims to stop a common ICU harm
Prevention Not yet recruitingThis trial tests whether a nursing care bundle created with the help of artificial intelligence can prevent medical device-related pressure injuries in intensive care patients. These injuries, which can be painful and serious, affect about 1 in 5 ICU patients. The study will comp…
Sponsor: Koç University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can AI protect Kids' eyesight where eye doctors are scarce?
Prevention Not yet recruitingResearchers are testing whether an artificial intelligence tool can sort children by their risk of nearsightedness and guide personalized prevention, such as more outdoor time and special glasses. The trial enrolls about 1,600 students in grades 1 through 3 from public primary sc…
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can yoga ease the pain of endometriosis after surgery?
Symptom relief Not yet recruitingThis trial tests whether adding a structured yoga therapy program to standard surgery for endometriosis can reduce chronic pain and improve quality of life. About 188 women scheduled for endometriosis surgery will either receive standard care alone or standard care plus 32 guided…
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Mindfulness on your phone: a new test for sickle cell pain and sleep
Symptom relief Not yet recruitingThis trial tests whether a smartphone-based mindfulness program can help adolescents and young adults with sickle cell disease manage chronic pain and sleep problems. Participants are randomly assigned to either use the mindfulness app for about 8 weeks or receive usual care. The…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Newer sedative faces off against propofol in heart patients
Symptom relief Not yet recruitingResearchers compare two sedatives, remimazolam and propofol, for patients with heart disease who need a transesophageal echocardiogram (TEE), a procedure that uses a tube in the esophagus to take pictures of the heart. Adults scheduled for an elective TEE receive one of the two d…
Phase 4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can steroids, a migraine drug, or tongue exercises save nerves after throat cancer treatment?
Symptom relief Not yet recruitingPeople treated with radiation for oropharyngeal cancer can later develop damage to cranial nerves, especially the nerve that controls the tongue. This trial tests four approaches to see if they are safe and practical: high-dose prednisone, the injectable drug fremanezumab, a home…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
New foam could offer relief for rare skin bumps
Symptom relief Not yet recruitingThis study tests a medicated foam (AMZEEQ®) on a rare skin condition called CARP, which causes brown, scaly patches. About 35 people aged 9 and older will apply the foam to one side of their body and a plain moisturizer to the other for 5 weeks. The goal is to see if the foam is …
Early phase 1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a classroom game help preschoolers learn to think flexibly?
Symptom relief Not yet recruitingResearchers are testing whether a school-based program called Unstuck and On Target for Early Childhood can help 4- and 5-year-olds with executive function deficits. Executive function covers skills like planning, staying flexible, and managing emotions. The program uses storyboo…
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Enzyme pill tested to calm celiac gut symptoms
Symptom relief Not yet recruitingResearchers are testing whether a dietary supplement called Galactol improves overall well-being and reduces gastrointestinal symptoms in adults with celiac disease who have functional abdominal bloating. The study enrolls 50 people aged 18 to 70. Participants take either Galacto…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a chatbot keep dialysis patients on track between sessions?
Symptom relief Not yet recruitingPeople on hemodialysis must closely manage fluid, diet, and their vascular access between sessions, and sticking to these routines is hard. Researchers at the University of Rome Tor Vergata built DialysisBot, an AI chatbot that answers patient questions using only a hospital-appr…
Sponsor: University of Rome Tor Vergata • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
New study aims to find best therapy for angry outbursts in kids
Symptom relief Not yet recruitingThis study compares three types of therapy for children aged 8 to 16.5 with severe irritability. Participants will receive either exposure-based cognitive behavioral therapy, parent management training, or supportive psychoeducation over 12 sessions. The goal is to see which appr…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Zapping the Brain's fear center: a new approach to depression
Symptom relief Not yet recruitingResearchers are testing a noninvasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in adults with major depressive disorder. The trial randomly assigns 60 participants to receive either active stimulation targeting the amygdala or a sha…
Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Could pine bark ease gulf war symptoms? small trial aims to find out
Symptom relief Not yet recruitingThis study will test whether Pycnogenol, a supplement from French maritime pine bark, can reduce symptoms of Gulf War Illness like fatigue, pain, and brain fog. Twenty male veterans who have already been in a related study will take either Pycnogenol or a placebo for up to 12 mon…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Food as medicine: keto diet tested for bipolar disorder in rural south
Symptom relief Not yet recruitingThis pilot study will test whether a high-fat, low-carbohydrate ketogenic diet can reduce symptoms of bipolar disorder when added to standard treatments. The study will enroll 100 adults in rural Alabama and measure changes in mania severity. The goal is to see if a dietary appro…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a 6-Week online program sharpen everyday thinking?
Symptom relief Not yet recruitingThis pilot study explores whether a personalized telerehabilitation program can help adults who notice cognitive slips in daily life. Participants include older adults and adults with Ehlers-Danlos Syndrome who report subjective cognitive complaints. Over six weeks, they receive …
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Zapping nerves without a scalpel: can radiofrequency quiet chronic pain?
Symptom relief Not yet recruitingResearchers are testing whether a noninvasive device called Hypersound can reduce chronic neuropathic or radicular pain in adults. The system uses external antennas to deliver radiofrequency energy to peripheral nerves without implants or needles. About 71 participants receive te…
Sponsor: Hypersound Medical Inc • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can zapping the ear calm HIV nerve pain?
Symptom relief Not yet recruitingResearchers at the University of Miami are testing a non-invasive ear stimulation treatment to understand nerve pain in older adults living with HIV. The study enrolls 70 people with HIV-associated peripheral neuropathy, a condition that causes tingling, numbness, or pain in the …
Sponsor: University of Miami • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Normal hearing test, real trouble: can hearing aids help?
Symptom relief Not yet recruitingDuke University researchers are studying whether hearing aids help adults who report hearing difficulty in daily life even though standard hearing tests show normal hearing. The trial enrolls 125 adults who have not used hearing aids before. Participants try hearing aids with dif…
Sponsor: Duke University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
One 2-Hour class may help new mothers manage Post-Cesarean pain
Symptom relief Not yet recruitingStanford researchers are testing whether a single 120-minute pain relief class called Empowered Relief can help women with severe pain after cesarean delivery. The class teaches pain education, relaxation, deep breathing, and cognitive behavioral skills, and participants receive …
Sponsor: Stanford University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab (Keytruda), a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog and dizziness in people with long COVID. Fifteen adults who had COVID-19 at least six months ago and still have…
Phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a sleep drug help cirrhosis patients rest and think clearer?
Symptom relief Not yet recruitingMany people with liver cirrhosis struggle with poor sleep, which can affect daily life and thinking. This trial tests daridorexant, a sleep medication, against placebo in 180 adults with cirrhosis and sleep disturbance, including some with mild hepatic encephalopathy. Participant…
Phase 4 • Sponsor: Wang Fengmei • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Inflatable leg cuffs tested as a Two-for-One therapy for high blood pressure and erectile dysfunction
Symptom relief Not yet recruitingResearchers are testing whether enhanced external counterpulsation (EECP), a noninvasive treatment that uses inflatable cuffs on the legs and buttocks timed to the heartbeat, can improve blood pressure and erectile function in men aged 60 to 75 who have both hypertension and erec…
Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Could a higher dose of an Alzheimer's drug boost thinking skills in down syndrome?
Symptom relief Not yet recruitingThis early-stage trial will test whether higher-than-standard doses of memantine, a drug already approved for Alzheimer's, are safe and tolerable in 25 adolescents and young adults with Down syndrome. The study also looks for early signs that the drug might improve memory and thi…
Phase 1 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
VR headset may calm kids before heart procedure
Symptom relief Not yet recruitingChildren scheduled for angiography often feel anxious, which can affect their heart rate, blood pressure and cooperation during the procedure. This trial tests whether a short virtual reality guided breathing exercise, delivered through a headset showing calming scenery, can redu…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Blood-flow cuffs may mimic exercise to ease Parkinson's symptoms
Symptom relief Not yet recruitingThis trial tests whether ischemic conditioning — brief cycles of blood-flow restriction using pressure cuffs on the arms — can improve motor function and cognitive performance in people with Parkinson's disease. Over 12 weeks, 34 participants will receive 24 sessions of the thera…
Sponsor: Hospital Israelita Albert Einstein • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a nurse coach couples back to intimacy after prostate cancer?
Symptom relief Not yet recruitingResearchers are testing a six-week, nurse-led program that helps Chinese prostate cancer survivors and their female partners talk about sex, rebuild intimacy, and cope together after treatment. About 72 couples join the study, with half receiving the program plus standard survivo…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a Text-Message program help trauma survivors avoid PTSD and depression?
Symptom relief Not yet recruitingPeople hospitalized after a traumatic injury often face post-traumatic stress, depression, and substance use problems. This study tests a program called Trauma Resilience and Recovery Program Portal 2.0, which adds bedside screening, education, text-message check-ins, and follow-…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Moving patterns may help stroke survivors read faster
Symptom relief Not yet recruitingResearchers test whether optokinetic stimulation without a reading task improves reading speed in adults with hemianopic alexia after stroke. Participants receive 4 weeks of stimulation without a reading task and 4 weeks with a reading task, in random order. The study compares re…
Sponsor: Clinique Les Trois Soleils • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can VR help people with dementia master daily tasks?
Symptom relief Not yet recruitingResearchers at Indiana University are testing whether a home-based virtual reality program can help people with mild dementia practice everyday activities like preparing food, washing dishes, or managing money. Forty participants will be randomly assigned to either VR training or…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
One shot to the knee: gene therapy tested against arthritis pain
Symptom relief Not yet recruitingResearchers are testing whether a single injection of an experimental gene therapy called GNSC-001 can reduce knee osteoarthritis pain and improve joint function in adults. The trial enrolls about 240 people with moderate knee arthritis confirmed by X-ray. Participants receive on…
Phase 2/3 • Sponsor: Genascence Corporation • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a 20-Hour infusion break the PTSD-Alcohol cycle?
Symptom relief Not yet recruitingResearchers are testing whether brexanolone, an intravenous drug approved for postpartum depression, can reduce PTSD symptoms and stress-related drinking in veterans who have both PTSD and alcohol use disorder. The study enrolls 40 veterans aged 21 to 70. Participants receive one…
Phase 2 • Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Vibrating wearables put stroke walking to the test
Symptom relief Not yet recruitingStroke survivors often walk more slowly and struggle to produce the movements needed for efficient walking. This study tests whether small wearable devices that vibrate during walking can help people with chronic stroke change specific walking movements linked to speed, propulsio…
Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Brain-Training trial aims to turn down the ringing
Symptom relief Not yet recruitingResearchers at the University of Zurich are testing whether neurofeedback can ease chronic tinnitus, the persistent ringing or buzzing that affects hearing and quality of life. The study enrolls 24 adults with moderate to severe tinnitus for about nine months. Participants attend…
Sponsor: University of Zurich • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Parkinson's patients may move better with music therapy
Symptom relief Not yet recruitingThis pilot study will test whether active music therapy (with a therapist) or passive music therapy (just listening to music) can improve exercise ability and motivation in 28 people with Parkinson's disease. Participants will do sit-to-stand and walking tests while receiving mus…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Laughter yoga: a surprising cure for nurse burnout?
Symptom relief Not yet recruitingThis study tests whether a structured laughter yoga program can reduce burnout, stress, and compassion fatigue in nurse managers. Eighty nurse managers will either join laughter yoga sessions twice a week for 8 weeks or continue as usual. Researchers will measure changes in stres…
Sponsor: Zonguldak Bulent Ecevit University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Could lasers replace the Dentist's drill? trial puts Er:YAG to the test
Symptom relief Not yet recruitingResearchers compare Er:YAG laser cavity preparation with conventional rotary drills in adults who have permanent premolars scheduled for extraction as part of orthodontic treatment. Each participant receives both methods on two different teeth, at separate visits, and rates pain …
Sponsor: Ho Chi Minh City Odonto-Stomatology Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can focused electrical fields deep in the brain ease Parkinson's tremors?
Symptom relief Not yet recruitingResearchers at Tongji Hospital are testing a non-invasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in 26 people with Parkinson's disease. The study uses MRI scans to customize electrode placement so the stimulation reaches deep brai…
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can qigong loosen the grip of fibromyalgia? trial tests two styles
Symptom relief Not yet recruitingResearchers are testing whether Qigong, a mind-body exercise, can improve spinal mobility and reduce pain in women with fibromyalgia. The trial randomly assigns 36 women aged 30 to 50 to one of two online Qigong programs: one focused on fluid, mobility-intensive movements, the ot…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Could a pill replace an IV for gum surgery pain relief?
Symptom relief Not yet recruitingResearchers are testing whether dexamethasone, a steroid that reduces inflammation, works as well when taken by mouth as when given through a vein. The trial enrolls 40 adults with periodontitis who need two similar gum flap surgeries. Each participant has both surgeries and rece…
Phase 1/2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
Symptom relief Not yet recruitingResearchers at Hospital Universitario Austral in Argentina are testing whether a structured three-session music therapy program called MUSPAL360 can be delivered to hospitalized adults with advanced cancer receiving palliative care. The program combines live music therapy with 36…
Sponsor: Austral University, Argentina • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Two lens designs go Head-to-Head for aging eyes
Symptom relief Not yet recruitingResearchers compare two monthly replacement silicone hydrogel multifocal toric contact lenses in people over 40 who already wear soft contacts. The study measures how easy the lenses are to handle, especially removal, and other performance factors. About 60 participants with asti…
Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Leg cuffs plus walking: a new way to steady Parkinson's balance?
Symptom relief Not yet recruitingPeople with Parkinson's disease often struggle with balance and anxiety, and the two can make each other worse, especially when they try to walk and think at the same time. High-intensity aerobic exercise may help both, but Parkinson's symptoms make it hard for many to reach that…
Sponsor: National Cheng-Kung University Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can an online wellness course ease the crushing fatigue of progressive MS?
Symptom relief Not yet recruitingResearchers at the University of Iowa are testing whether an online wellness program can reduce fatigue and improve mood and quality of life in people aged 45 to 70 with progressive multiple sclerosis. Participants are randomly assigned to get the program right away or to continu…
Sponsor: University of Iowa • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can digital questionnaires improve life during pancreatic cancer therapy?
Symptom relief Not yet recruitingResearchers at MD Anderson Cancer Center are studying whether routine electronic symptom monitoring improves quality of life and care experience for patients with pancreatic adenocarcinoma receiving chemotherapy or radiation before surgery. About 200 adults with operable or local…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Structured recovery pathway tested for faster healing after placenta previa cesarean
Symptom relief Not yet recruitingResearchers are testing whether a standardized Enhanced Recovery After Surgery (ERAS) pathway improves recovery for women who have a cesarean delivery because of placenta previa. The study includes 100 women with a singleton pregnancy and a confirmed placenta previa who are sched…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Stem cell signals could help rebuild jawbone for dental implants
Symptom relief Not yet recruitingResearchers are testing whether signaling molecules made by a patient's own fat-derived stem cells can help synthetic bone grafts build stronger jawbone. The trial enrolls 20 adults with severe upper-jaw bone loss who need sinus floor augmentation before dental implants. Each par…
Phase 1 • Sponsor: Pontificia Universidade Católica do Rio Grande do Sul • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can a Weight-Loss drug also calm a painful skin disease?
Symptom relief Not yet recruitingResearchers are testing an experimental drug called olatorepatide in adults with moderate to severe hidradenitis suppurativa who also live with overweight or obesity. Hidradenitis suppurativa causes painful lumps and tunnels under the skin. The trial compares olatorepatide with a…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
New supplement shows promise for fibromyalgia sufferers
Symptom relief Not yet recruitingThis study tests whether a supplement called FibroThol (containing 2-Aticyto Complex and D-ribose) can help reduce pain and other symptoms in people with fibromyalgia. About 200 adults aged 18 to 65 who have had fibromyalgia for at least a year and are already on standard medicat…
Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Knotless suture technique aims to hold rotator cuff repairs together like a hot air balloon
Symptom relief Not yet recruitingResearchers are studying a surgical method for repairing rotator cuff tears that uses two rows of anchors and sutures without knots, called the Montgolfier technique. The sutures spread tension evenly around the repair, similar to the cables of a hot air balloon. Adults scheduled…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Zapping a social brain region: can magnetic pulses help teens with autism read social cues?
Symptom relief Not yet recruitingResearchers are testing whether transcranial magnetic stimulation (TMS) can improve social perception in adolescents with autism spectrum disorder. The trial targets the right posterior superior temporal sulcus, a brain region involved in processing social information. Sixteen pa…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Magnetic pulses to the brain target gambling cravings
Symptom relief Not yet recruitingResearchers at Sveti Ivan Psychiatric Hospital are testing whether high-frequency repetitive transcranial magnetic stimulation (rTMS) with the H7 coil reduces gambling disorder symptoms. The trial enrolls 60 men aged 18 to 64 who are starting treatment at a gambling disorder day …
Sponsor: Sveti Ivan Psychiatric Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can High-Flow oxygen make heart valve surgery safer for seniors?
Symptom relief Not yet recruitingThis study tests whether giving high-flow oxygen through special nasal prongs during a less-invasive heart valve replacement (TAVR) can prevent low oxygen levels and breathing complications. About 452 older adults undergoing TAVR under sedation will be randomly assigned to receiv…
Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a cannabis tincture quiet an anxious mind?
Symptom relief Not yet recruitingResearchers are studying whether a broad-spectrum oral tincture containing CBD, CBN, and CBG changes anxiety symptoms in adults with generalized anxiety disorder. About 60 participants will take the tincture under the tongue or by mouth roughly every 12 hours for 8 weeks, with fo…
Sponsor: Associação Pan-Americana Multidisciplinar de Endocanabinologia • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Comfort-Focused education program improve life with epilepsy?
Symptom relief Not yet recruitingResearchers are testing whether a structured educational program based on Kolcaba's Comfort Theory can improve quality of life for adults with epilepsy. The program addresses physical, emotional, social, and environmental comfort needs through planned sessions delivered alongside…
Sponsor: Ataturk University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a poop transplant ease autism? small trial aims to find out
Symptom relief Not yet recruitingThis early-phase trial tests whether giving adults with autism a 6-week course of vancomycin followed by a fecal transplant from a close relative can improve social and language problems. Ten participants will be tracked for changes in autism symptoms, quality of life, and gut he…
Phase 1 • Sponsor: ProgenaBiome • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to calm painful skin flares
Symptom relief Not yet recruitingResearchers are testing an experimental oral drug called soquelitinib in adults with moderate-to-severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and tunnels. The trial aims to see if the drug is safe and can reduce the number of inflammatory le…
Phase 1 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual reality help children with brain injury regain hand control?
Symptom relief Not yet recruitingResearchers compare two rehabilitation approaches for children with cerebral palsy and immature brain injury: virtual reality training and task-oriented circuit training. Both aim to improve upper limb sensorimotor function, pinch grip, and quality of life. Forty-four children ag…
Sponsor: October 6 University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
A single zoom class might ease cancer pain for american indians
Symptom relief Not yet recruitingThis trial tests whether a single, two-hour online class called Empowered Relief can help American Indian adults with cancer-related pain. Participants learn three pain relief skills, create a personal plan, and get access to a free audio app for daily practice. The study aims to…
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Two shockwave types go head to head for stubborn heel pain
Symptom relief Not yet recruitingResearchers are comparing two forms of shockwave therapy, focused and radial, for adults with chronic plantar fasciitis, a common cause of heel pain. About 150 participants receive three weekly treatment sessions and then answer questions about pain and foot function for up to a …
Sponsor: Homerton University Hospital NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can an AI chatbot help cancer patients kick the habit?
Symptom relief Not yet recruitingResearchers are testing whether an AI chatbot on WeChat helps early-stage cancer patients quit smoking. The chatbot uses the Multi-Theory Model to offer personalized advice, emotional support, and habit tracking around the clock. The trial compares the chatbot with phone-based pr…
Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a personal navigator help young cancer patients through treatment?
Symptom relief Not yet recruitingResearchers at the University of North Carolina are testing a support program for young adults aged 18 to 39 who are receiving cancer treatment. A trained navigator contacts each participant at least once a month for four months by phone, text, email, or video, based on what the …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can adding common pain drugs reduce morphine needs in sickle cell crises?
Symptom relief Not yet recruitingAdults with sickle cell disease often face severe pain crises that require hospital treatment with intravenous morphine. This trial compares standard morphine treatment with combinations that add paracetamol, ketamine, or nefopam. Researchers want to see if these combinations eas…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a phone app that blocks distracting apps ease depression?
Symptom relief Not yet recruitingResearchers at the University of Bergen are testing whether a two-week, self-guided smartphone screen time reduction program can reduce depression symptoms in young adults. The trial enrolls 200 students in Oslo who have sought help at the student mental health service. Participa…
Sponsor: University of Bergen • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans vs tape measures: which TMS targeting works best for depression?
Symptom relief Not yet recruitingThis study tests whether using a person's brain scan (MRI) to guide TMS treatment for depression works better than the standard scalp-measurement method. 160 adults with major depression will receive accelerated TMS (10 sessions a day for 5 days) with either MRI or scalp targetin…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a special screen light reduce tired eyes and dryness?
Symptom relief Not yet recruitingThis study tests whether a full-spectrum screen bar light can reduce eye fatigue and dry eye symptoms after two hours of computer work. Healthy adults aged 18 to 35 who use screens at least four hours daily will be randomly assigned to use the light or a standard screen without i…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Allergy pill put to the test against endometriosis pain
Symptom relief Not yet recruitingEndometriosis causes chronic pelvic pain and painful periods, and current treatments do not work for everyone. Researchers are testing whether desloratadine, an antihistamine usually taken for allergies, can reduce pain and improve quality of life. The trial enrolls 60 women aged…
Phase 2 • Sponsor: Medical University of Vienna • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can mindfulness and yoga rewire diabetes habits?
Symptom relief Not yet recruitingResearchers are testing a program that combines mindful eating and yoga-based movement for adults with type 2 diabetes. The trial enrolls 60 people aged 40 and older who have had diabetes for at least six months. Half receive the mindfulness program and half receive standard diet…
Sponsor: Northeastern University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can Pre-Surgery pelvic floor therapy stop endometriosis pain after the operation?
Symptom relief Not yet recruitingEndometriosis is a long-term condition where tissue like the uterine lining grows outside the uterus, often causing lasting pelvic pain. Surgery can help, but pain sometimes remains afterward. Researchers are testing whether a structured pelvic floor physiotherapy program done be…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Five-Session therapy ease distress and calm stress biology in Late-Stage breast cancer?
Symptom relief Not yet recruitingResearchers are testing a five-session meaning-centered psychotherapy called CASA in Puerto Rican patients with Stage III or IV breast cancer and their caregivers. The trial compares CASA with usual care in about 114 people to see whether the therapy reduces psychological distres…
Phase 1 • Sponsor: Ponce Medical School Foundation, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Nurse-Led asthma program aims to help patients breathe easier
Symptom relief Not yet recruitingThis pilot study tests a 12-month structured nursing program called RESPiraIA-Asma for adults with poorly controlled, non-severe asthma. The program combines education, inhaler training, home peak-flow monitoring, and personalized care plans, offered in-person, digitally, or mixe…
Sponsor: Hospital San Carlos, Madrid • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Marijuana pill may boost CPAP use in sleep apnea patients
Symptom relief Not yet recruitingThis study tests whether taking dronabinol (a cannabis-derived medication) before bed can help people with obstructive sleep apnea use their CPAP machine more consistently. Researchers will also check if combining CPAP with dronabinol improves sleep quality and blood pressure. Th…
Phase 2/3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual reality rewire balance and leg control in cerebral palsy?
Symptom relief Not yet recruitingResearchers compare two exercise-based therapies for children with spastic cerebral palsy: virtual reality therapy and plyometric exercise training. The trial enrolls 44 children aged 12 to 18 who can stand alone and have mild to moderate mobility limits. Children in the virtual …
Sponsor: October 6 University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can jaw and neck exercises ease TMJ pain?
Symptom relief Not yet recruitingResearchers test whether a combination of orofacial myofunctional therapy and cervical stabilization exercises can reduce jaw pain and improve function in adults with anterior disc displacement with reduction, a common temporomandibular disorder. The trial enrolls 80 adults aged …
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Self-Balancing exoskeleton make daily tasks more satisfying than a wheelchair?
Symptom relief Not yet recruitingResearchers compare how people with paraplegia perform and feel about four daily tasks when using a self-balancing exoskeleton versus a manual wheelchair. Five participants attend daily sessions where they do tasks like making coffee or brushing teeth with each device. The study …
Sponsor: Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a breathing workout and walks help dialysis patients with irregular heartbeats?
Symptom relief Not yet recruitingResearchers test whether adding inspiratory muscle training to a walking program helps adults on hemodialysis who also have atrial fibrillation. Participants do breathing exercises through a mouthpiece and walk for six minutes, while the study tracks heart rate, blood pressure, k…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can pressing six points on the body help older adults sleep?
Symptom relief Not yet recruitingResearchers are testing whether older adults with high blood pressure who report insomnia can improve their sleep by pressing six acupoints on themselves each night for 28 days. The trial compares this self-acupressure routine with sleep hygiene training in 94 participants aged 6…
Sponsor: Phenikaa University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Teaching the brain to tame pain: a virtual approach to enhance spinal cord stimulation
Symptom relief Not yet recruitingThis pilot trial tests whether adding virtual pain neuroscience education to standard spinal cord stimulation can help chronic pain patients better manage their condition. The education teaches how the brain processes pain, aiming to reduce fear, anxiety, and catastrophizing. Par…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a weekly weight drug quiet gout attacks?
Symptom relief Not yet recruitingResearchers are testing whether mazdutide, a weekly injected drug, reduces the number of gout flares in adults who have both obesity and gout. The study enrolls 30 people aged 18 to 65 with a BMI of at least 30 and at least two gout flares in the past six months. Everyone receive…
Phase 4 • Sponsor: Hongwei Jiang • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a video game teach cancer patients to tame their pain?
Symptom relief Not yet recruitingResearchers at Dana-Farber Cancer Institute are testing Healing Gardens, a mobile game that delivers pain-focused cognitive behavioral therapy and cancer pain education. The study enrolls 46 adults with advanced solid tumors who have chronic pain related to cancer or its treatmen…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Cash rewards and coaching put to the test for Post-Surgery walking
Symptom relief Not yet recruitingMany people with lumbar spinal stenosis get pain relief from decompression surgery but still do not walk more afterward. This pilot trial tests whether a behavioral program can change that. Researchers randomly assign 75 patients aged 40 to 85 to either the program, which pairs m…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can spiritual workshops ease Cancer's existential pain?
Symptom relief Not yet recruitingThis study tests a spiritual health program called PATH for cancer patients struggling with feelings of disconnection, loss of meaning, or existential distress. Twenty adults with any stage of cancer will attend six workshops combining role-playing, psychology, and dignity therap…
Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New mask aims to make sleep apnea therapy easier to live with
Symptom relief Not yet recruitingResearchers are testing the F&P Licorice mask, a device used with PAP or NIV breathing machines, in people who have obstructive sleep apnea or other chronic respiratory conditions. The study follows about 45 adults who already use this type of therapy at home. Over roughly two we…
Sponsor: Fisher and Paykel Healthcare • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a free online program ease social anxiety? new study aims to find out.
Symptom relief Not yet recruitingThis study tests an online self-help tool called e-couch for adults with social anxiety. Over 5 weeks, 200 participants will use the program, which is based on cognitive behavioral therapy. Researchers will use surveys and computer tasks to predict who improves the most.
Sponsor: Trustees of Princeton University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Veterans with opioid addiction may soon get pain relief from a web program
Symptom relief Not yet recruitingThis Phase 3 trial will test a web-based program called IMPACT for 250 veterans who have both opioid use disorder and chronic pain. The program includes 9 online modules and weekly feedback from a coach, all done from home. The goal is to see if it reduces how much pain interfere…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Nerve blocks put to the test for chest tube pain
Symptom relief Not yet recruitingDoctors insert a chest tube to drain air or fluid from around the lungs, but the procedure often causes severe pain. This trial compares two ultrasound-guided nerve blocks, the serratus anterior plane block and the erector spinae plane block, to see which one better controls pain…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
Symptom relief Not yet recruitingThis trial tests whether an artificial intelligence chatbot can help men with prostate cancer better understand radiation therapy. Participants will use a plain-language chatbot alongside standard education from their care team. Researchers will measure changes in patients' confi…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New study tests if helping others can spark motivation in dementia patients
Symptom relief Not yet recruitingThis study tests two simple activities—volunteering inside the assisted living community or joining a current events discussion group—to see if they can reduce apathy in residents with mild to moderate memory problems. About 200 people aged 55 and older will take part for 6 month…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could fasting ease the misery of pancreatitis?
Symptom relief Not yet recruitingResearchers are testing whether intermittent fasting improves quality of life for adults with acute or chronic pancreatitis. Participants follow a daily 16-hour fast or receive standard calorie guidance. The study measures pancreas-related quality of life, pain, opioid use, weigh…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Two sedatives, one question: can remimazolam shield the brain during aortic arch surgery?
Symptom relief Not yet recruitingAortic arch surgery temporarily cuts blood flow to the brain, which can leave patients with lasting thinking and memory problems. Researchers at Seoul National University Hospital are testing whether anesthesia with remimazolam, rather than propofol, lowers the chance of that cog…
Phase 4 • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a faster recovery plan get kids home sooner after ileostomy reversal?
Symptom relief Not yet recruitingResearchers compare two approaches to care after ileostomy reversal surgery in children. One group receives the Enhanced Recovery After Surgery (ERAS) protocol, which includes early feeding, early catheter removal, early walking, and multimodal pain control. The other group recei…
Sponsor: Children Hospital Faisalabad • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a sugary drink before Weight-Loss surgery speed up gut recovery?
Symptom relief Not yet recruitingResearchers are testing whether a carbohydrate-rich clear drink given two hours before bariatric surgery helps patients with metabolic syndrome recover normal gastrointestinal function faster. About 208 adults scheduled for gastric bypass or sleeve gastrectomy will be randomly as…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a gut drug boost brain power in schizophrenia?
Symptom relief Not yet recruitingThis study tests whether prucalopride, a drug used for gut issues, can improve thinking and memory in people with schizophrenia. About 34 adults will take the drug for 4 weeks while staying on their usual medications. Researchers will measure changes in memory, attention, and pro…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can VR lessons help heart patients take their medicines?
Symptom relief Not yet recruitingResearchers are testing whether nurse-led lessons delivered through virtual reality or a tablet help people with coronary artery disease understand their heart risks and take their antiplatelet medicines as prescribed. The trial enrolls 54 adults aged 18 to 65 who have coronary a…
Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
A single shot into the ear: can a new drug quiet constant ringing?
Symptom relief Not yet recruitingResearchers are testing whether a one-time injection of an experimental drug called paliroden into the middle ear is safe and can help adults with chronic, constant tinnitus in both ears. Participants, ages 18 to 75, have normal hearing thresholds but struggle to understand speec…
Phase 1/2 • Sponsor: Cilcare SAS • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can an antipsychotic restore feelings in people with depression?
Symptom relief Not yet recruitingResearchers test whether adding lumateperone to ongoing antidepressant treatment reduces emotional blunting in adults with major depressive disorder. Emotional blunting means feeling numb or unable to experience pleasure or sadness. Thirty participants who score high on the Oxfor…
Phase 4 • Sponsor: Future Options Research, LLC • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can mindfulness help unhoused LGBTQ youth thrive? new study aims to find out.
Symptom relief Not yet recruitingThis study tests whether brief mindfulness and identity-affirming exercises can improve well-being and reduce mental health symptoms in LGBTQ youth aged 16-26 who are currently or recently unhoused. Two hundred participants will be randomly assigned to either the mindfulness prog…
Early phase 1 • Sponsor: Cornell University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Nerve-Block procedure tested against severe pancreatic and stomach cancer pain
Symptom relief Not yet recruitingResearchers are studying whether a procedure called fluoroscopy-guided transdiscal splanchnic nerve neurolysis can safely reduce severe upper abdominal pain in adults with pancreatic, gastric, or hepatobiliary cancer. Participants first receive a diagnostic nerve block with local…
Sponsor: Sahiwal medical college sahiwal • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Knee pain relief: targeted exercises show promise in small trial
Symptom relief Not yet recruitingThis study tests two types of exercise for people with a common knee condition called patellofemoral pain. One group does neuromuscular control exercises (like balance and coordination), the other does muscle strengthening. Researchers will measure pain, function, and movement in…
Sponsor: Universidade do Porto • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can electrical muscle stimulation boost exercise benefits after menopause?
Symptom relief Not yet recruitingResearchers are testing whether adding whole-body electromyostimulation (WB-EMS) to a supervised exercise program improves body composition, heart health, fitness, and quality of life in overweight or obese postmenopausal women. Thirty women aged 48 to 60 will join a 16-week prog…
Sponsor: High Institute of Sports and Physical Education of Kef • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a single drug dose curb opioid side effects after kidney stone surgery?
Symptom relief Not yet recruitingResearchers test whether a single intravenous dose of anrikefon, given near the end of kidney stone removal surgery, can reduce opioid-related side effects such as nausea, vomiting, itching, oversedation, and breathing problems in the first 24 hours after surgery. All 160 adult p…
Phase 4 • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Post-Training drink help young footballers recover and sleep better?
Symptom relief Not yet recruitingResearchers are testing whether a dietary supplement called KA-EX helps young elite football players recover after training. Players on the Udine Primavera team receive either KA-EX or a placebo powder mixed in water right after training for two months. The team tracks heart rate…
Sponsor: Antonio Molina Lopez • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?
Symptom relief Not yet recruitingMany people treated with aromatase inhibitors for early-stage breast cancer develop joint pain and stiffness that can make it hard to continue the therapy. This Phase II pilot study tests whether hydroxychloroquine, an anti-inflammatory drug often used for inflammatory joint cond…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a 10-Hour eating window fight cancer fatigue?
Symptom relief Not yet recruitingResearchers are testing whether time-restricted eating, where all food is eaten within a 10-hour window each day, can reduce fatigue and slow frailty in older adults living with prostate cancer or metastatic breast cancer. The trial enrolls 132 people aged 55 and older who typica…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Fatty meals may trap vitamin e in the blood, study suggests
Knowledge-focused Not yet recruitingThis study investigates how eating three high-fat meals in a row changes vitamin E levels in the blood. Researchers will compare people with normal blood fats to those with high blood fats (hyperlipidemia). The goal is to understand whether fats in the blood can trap vitamin E, p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Super-Resolution heart scans: sharper images without extra radiation?
Knowledge-focused Not yet recruitingThis study will take standard heart CT scans from 1000 adults with structural heart disease and use a super-computer to create ultra-high-resolution images. The goal is to see if these enhanced images show more detail than the originals. No new treatments are being tested; it's a…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Massive 30-Year study aims to unlock secrets of diabetes and obesity
Knowledge-focused Not yet recruitingThis study will follow 1,000 people aged 8 to 65 who are overweight, have high blood sugar, or have metabolic issues. Researchers will collect blood, saliva, urine, and stool samples during routine clinic visits, along with questionnaires about diet, sleep, and mood. The goal is …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Tiny study aims to find best way to check blood thinner levels in kids
Knowledge-focused Not yet recruitingThis study looks at 22 children with congenital heart disease who are getting a blood thinner called heparin. Doctors want to see if taking blood from a central line (a special IV) gives the same results as taking blood from an artery. They will compare three different ways of dr…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can hidden blood mutations ignite heart disease?
Knowledge-focused Not yet recruitingThis study investigates clonal hematopoiesis, an age-related condition where blood stem cells acquire mutations, and how it triggers inflammation linked to heart disease. Researchers will compare immune cells from healthy people, those with high-risk mutations, and patients with …
Sponsor: VASCage GmbH • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Scientists probe why rheumatic pain feels different for everyone
Knowledge-focused Not yet recruitingResearchers want to understand the different ways pain works in people with rheumatic diseases such as lupus, rheumatoid arthritis, and Sjogren's syndrome. The study enrolls up to 225 people aged 9 to 85 who have or may have a rheumatic disease, plus healthy volunteers matched by…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a common blood thinner be safe for ICU patients with liver issues?
Knowledge-focused Not yet recruitingThis study looks at whether a blood-thinning method called citrate anticoagulation is safe and practical for critically ill patients with acute kidney injury who may not process citrate normally. It follows 50 ICU patients who need kidney replacement therapy and are at risk for c…
Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
MS and motherhood: what shapes Women's choices?
Knowledge-focused Not yet recruitingWomen with multiple sclerosis face complex decisions about marriage, pregnancy, and motherhood. This study explores how women of reproductive age in Assiut Governorate, Egypt, make these choices. Researchers will survey married women using questionnaires and interview both marrie…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Breakfast showdown: High-Fat vs. High-Carb – which worsens blood fats?
Knowledge-focused Not yet recruitingThis study looks at how eating a high-fat or high-carb breakfast changes fat levels in the blood over 8 hours. Researchers will compare results among people with conditions like diabetes, fatty liver, or kidney disease, as well as healthy volunteers. Participants will have two ov…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a Nurse's confidence ease a Patient's postoperative pain?
Knowledge-focused Not yet recruitingResearchers ask whether surgical nurses' confidence in managing pain relates to how well their patients' pain is controlled after surgery. Nurses in general surgery clinics complete a questionnaire about their pain management self-efficacy, and their adult patients complete a sep…
Sponsor: Volkan Gokmen • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Four-Part check may reveal hidden malnutrition in sickest kids
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying how to identify malnutrition in critically ill children aged 1 month to 5 years admitted to a pediatric intensive care unit. The team uses a four-part ABCD approach that combines body measurements, blood markers, physical signs, and d…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New alert aims to curb opioid abuse by helping doctors pause and review
Knowledge-focused Not yet recruitingThis study tests a computer alert that notifies doctors when a patient is about to move into a new phase of opioid therapy, such as from short-term to long-term use. The alert prompts doctors to review the patient's pain and goals, following CDC guidelines. Researchers will study…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Finger-Prick blood tests could let lung cancer patients skip clinic visits
Knowledge-focused Not yet recruitingResearchers are testing whether people with non-small cell lung cancer can collect their own small blood samples at home using a finger-prick kit. Participants receive standard treatment with docetaxel, paclitaxel, alectinib, or lorlatinib, and the samples measure how much cancer…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New brain zapping technique tested for safety in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new form of transcranial magnetic stimulation (TMS) called high-density theta burst stimulation (hdTBS) in 35 healthy adults aged 22 to 60. The goal is to check if hdTBS is safe and to compare its effects on the brain to standard TMS. Participants w…
Phase 1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a daily probiotic change your gut and brain? new study investigates
Knowledge-focused Not yet recruitingThis study will give 180 healthy adults a daily probiotic supplement (Lactobacillus plantarum) for 1 or 6 months. Researchers will collect blood and stool samples and run online cognitive tests to see if the supplement changes gut bacteria, blood markers, or thinking skills. The …
Sponsor: OneCarbon • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Heart valve leaks after myectomy may resolve without extra surgery
Knowledge-focused Not yet recruitingResearchers at University Health Network in Toronto are reviewing the records of 150 adults who had septal myectomy for hypertrophic obstructive cardiomyopathy. They compare intraoperative echocardiograms with predischarge echocardiograms to see how often moderate or worse mitral…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Why do some leukemia patients develop dangerous blood clots?
Knowledge-focused Not yet recruitingResearchers are observing adults newly diagnosed with acute leukemia during their hospital stay to learn which factors raise the risk of venous thromboembolism, a serious blood clot condition. The study follows about 250 patients from admission to discharge or death, recording cl…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Blood, tears and saliva: the hunt for Migraine's hidden signature
Knowledge-focused Not yet recruitingResearchers want to know whether migraine leaves a measurable biological trace in the body. They will collect blood, saliva and tear fluid from 60 adults with episodic migraine, both during an attack and between attacks, and compare the samples with those from people who do not g…
Sponsor: Nordlandssykehuset HF • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can hormone cycles explain ADHD symptoms in teen girls?
Knowledge-focused Not yet recruitingResearchers at Duke University are studying how natural estrogen changes across the menstrual cycle relate to sleep and ADHD symptoms in girls aged 11 to 15. Participants will wear a Garmin device to track sleep, provide hormone samples, and answer quick surveys about mood and fo…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Which medicines and herbal products are damaging livers? egyptian hospital launches Two-Year hunt
Knowledge-focused Not yet recruitingResearchers at Al-Rajhi Liver Hospital in Assiut, Egypt, are studying drug-induced liver injury, a form of liver damage caused by prescription medicines, over-the-counter drugs, herbal products, or dietary supplements. The study has two parts: a review of past medical records fro…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New pain test battery could speed up drug development
Knowledge-focused Not yet recruitingThis pilot study will test a new method to see how two pain medicines, naproxen and pregabalin, work in healthy adults. Up to 25 participants will receive each medicine and a placebo in random order. They will undergo several short, controlled pain tests, like a cold water hand b…
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can regional data improve bone marrow transplant results for blood cancers?
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying adults with blood cancers who receive an autologous hematopoietic stem cell transplant, a procedure that uses a patient's own stem cells. The study follows 123 participants to measure survival, progression-free survival, complications…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New study to uncover why stem cell transplants harm the liver
Knowledge-focused Not yet recruitingThis study follows 500 adults and children who are getting a stem cell transplant to see how their liver is affected. Researchers will track liver function, perform biopsies and scans, and look for factors that lead to liver damage. The goal is to better understand and eventually…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New study will track how well custom joint implants work over 5 years
Knowledge-focused Not yet recruitingThis study will follow 2,000 adults who receive a custom-made joint implant (knee, hip, foot/ankle, or shoulder) to see how they recover over 5 years. Participants fill out surveys from home about pain, function, and quality of life before surgery and at regular intervals afterwa…
Sponsor: Restor3D • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a High-Phenolic ancient grain rewire metabolism?
Knowledge-focused Not yet recruitingResearchers are testing whether whole grain sorghum improves immune and metabolic health in adults with excess weight, and whether phenolic compounds in the grain drive those effects. Thirty participants eat foods made from high-phenolic sumac sorghum, low-phenolic white sorghum,…
Sponsor: University of Nebraska Lincoln • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Heart hope for HS patients: drug may slow artery plaque
Knowledge-focused Not yet recruitingThis study follows 34 adults with moderate-to-severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their routine care. Researchers will use a special CT scan to check if the drug affects the buildup of plaque in the heart arteries over 12 months. The goal is…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can Weight-Loss surgery ease a pain in the neck?
Knowledge-focused Not yet recruitingResearchers want to know whether weight loss from laparoscopic sleeve gastrectomy changes neck pain, posture, and neck function. The study follows about 25 adults scheduled for this weight-loss operation at one hospital. Participants complete neck questionnaires, strength and mot…
Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Your childhood may be driving your food choices: new study investigates
Knowledge-focused Not yet recruitingThis natural history study looks at how life events during childhood might affect eating behaviors and weight gain in adults. Researchers will observe 110 healthy volunteers aged 18 to 60, measuring food intake, physical activity, blood sugar, and body fat. Participants will also…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Which early signs foretell recovery in childhood encephalitis?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are tracking 88 children with encephalitis to see which clinical, laboratory, and imaging findings at admission relate to early neurological outcomes. The study measures functional status at discharge using a standard scale, alon…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Refugee sleep secrets: study seeks answers
Knowledge-focused Not yet recruitingThis study looks at how stress from being a refugee—like trauma, discrimination, and adjusting to a new culture—affects sleep in Bhutanese refugees living in Ohio. Researchers will hold focus groups and interviews with 70 adults to understand their sleep problems and coping strat…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a tiny fat sample predict childhood obesity?
Knowledge-focused Not yet recruitingResearchers want to know whether biological markers in blood and fat tissue can flag a young child's risk of becoming overweight later. The study enrolls 400 children under age 4 who are already scheduled for surgery, collecting a small blood sample and two tiny fat samples durin…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a Once-Weekly shot cut the burden of hemophilia a?
Knowledge-focused Not yet recruitingResearchers are studying how switching to efanesoctocog alfa (ALTUVOCT), a long-acting factor VIII therapy given once a week, affects adults and children with severe or moderate hemophilia A in routine care. The study tracks factor use, treatment satisfaction, and quality of life…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a 20-minute HIIT session shift prostate cancer hormone levels?
Knowledge-focused Not yet recruitingThis study looks at how a short, home-based high-intensity workout affects steroid hormones in men with low-grade prostate cancer who are on active surveillance. About 49 men will do one supervised bodyweight HIIT session and provide saliva samples. The goal is to see if the exer…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can a scan predict who gets knee pain relief?
Knowledge-focused Not yet recruitingThis study will use special PET/MRI scans to look at changes in knee metabolism after a procedure called genicular artery embolization (GAE) for knee osteoarthritis. The goal is to understand why some people get good pain relief and others do not. About 25 adults with moderate to…
Sponsor: Lucas R. Cusumano, MD • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New study to uncover why bhutanese americans face higher heart risks
Knowledge-focused Not yet recruitingThis natural history study will explore how life experiences and environmental factors affect heart health and metabolism among 50 Bhutanese adults living in the US. Participants will complete a survey and discuss their views on providing biological samples. The goal is to identi…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Childhood obesity and early puberty: a new study seeks answers
Knowledge-focused Not yet recruitingThis study follows 400 children aged 5 to 7 with obesity or normal weight until age 12. Researchers will track puberty signs, hormones, genes, diet, and chemical exposures to see what predicts early puberty. No treatments are given; the goal is to gather information.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New biorepository aims to unlock secrets of pulmonary hypertension
Knowledge-focused Not yet recruitingThis study is creating a large collection of blood samples and medical information from 1000 adults with or suspected of having pulmonary hypertension (PH). Researchers hope this resource will help them find new ways to diagnose and treat PH. Participants will provide a blood sam…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can your nose predict brain health? new study tests smell and choices in HIV and addiction
Knowledge-focused Not yet recruitingThis study looks at how HIV and substance use disorder (SUD) affect the sense of smell and decision-making. Researchers will test 120 adults aged 18–65, including people with HIV, SUD, both, or neither. Participants will complete smell tests and computer tasks over two visits, an…
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New scale aims to help IBD patients manage their own care
Knowledge-focused Not yet recruitingThis study is building a new questionnaire to measure how well people with inflammatory bowel disease (IBD) take care of themselves. Researchers will talk to 275 adults with Crohn's disease or ulcerative colitis to understand their self-care habits, then test the questionnaire to…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Your mood may be steering your choices: scientists track emotions to predict behavior
Knowledge-focused Not yet recruitingResearchers at the National Institute of Mental Health are studying how everyday feelings, like stress or frustration, influence decision-making. They will follow 420 adults aged 18 to 55, including healthy volunteers and people with varying levels of depression, anxiety, or addi…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Blood test may reveal why some MDS patients feel worn out on luspatercept
Knowledge-focused Not yet recruitingResearchers are studying blood samples from 150 adults with lower-risk myelodysplastic syndromes (MDS) who receive luspatercept, a drug that boosts red blood cell production. The goal is to find metabolites and other biomarkers linked to fatigue, a common side effect of the treat…
Phase 4 • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Could a blood protein reveal hidden heart risks in sleep apnea?
Knowledge-focused Not yet recruitingResearchers are studying whether a blood protein called adropin can signal blood vessel damage and disease severity in obese adults with obstructive sleep apnea. The trial compares adropin levels in obese patients with and without the sleep disorder, and checks how those levels r…
Sponsor: Aswan University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can coaching school staff raise the quality of autism programs?
Knowledge-focused Not yet recruitingResearchers at Stockholm University are testing whether an autism program quality tool called APERS can help special education units improve. School staff in the experimental group receive feedback, training, and ongoing coaching from specially trained coaches, while a comparison…
Sponsor: Stockholm University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
A tiny touch test aims to map lost sensation in the throat
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are studying how well a calibrated touch device measures sensation in the larynx and throat. The study includes adults with larynx or throat disorders, including those whose condition followed radiation or other cancer tr…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Ambulance video calls could revolutionize stroke triage
Knowledge-focused Not yet recruitingThis study tests whether having a neurologist consult via video during ambulance transport helps decide the best hospital for suspected stroke patients. About 484 adults with stroke symptoms will be randomly assigned to standard care or standard care plus a telemedicine consultat…
Sponsor: Nyika D. Kruyt • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Underactive thyroid may worsen liver scarring in fatty liver disease
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying whether an underactive thyroid makes liver scarring worse in people with metabolic dysfunction-associated steatotic liver disease (MASLD). The trial enrolls 120 adults with MASLD, half of whom have overt or subclinical hypothyroidism …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Desk jobs and aching bodies: what Lawyers' activity levels reveal
Knowledge-focused Not yet recruitingResearchers at Suleyman Demirel University are surveying lawyers registered with the Isparta Bar Association to understand how physical activity, stress, burnout, and job satisfaction relate to musculoskeletal pain. About 102 lawyers with at least five years of experience answer …
Sponsor: Suleyman Demirel University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can difficulty naming emotions shape how much tailbone pain you feel?
Knowledge-focused Not yet recruitingResearchers at Marmara University are studying whether alexithymia, a trait where people struggle to identify and describe their feelings, relates to pain intensity, quality of life, anxiety, depression, and childhood trauma in adults with chronic coccydynia. Participants have ha…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can four minutes of hard exercise match a longer workout for blood sugar?
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are testing whether short bursts of high-intensity exercise control blood sugar as well as longer, moderate workouts. The study enrolls 12 non-diabetic or pre-diabetic adults who wear a continuous glucose monitor for 11 d…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can better nurse training reduce ICU complications?
Knowledge-focused Not yet recruitingThis trial tests whether a structured training program for ICU nurses, focusing on respiratory and renal care with case-based discussions, improves their clinical reasoning, knowledge, and collaboration with doctors. The study involves 140 participants, including nurses and mecha…
Sponsor: Hiroshima University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can Real-World data match trial results for pembrolizumab in Triple-Negative breast cancer?
Knowledge-focused Not yet recruitingResearchers in Korea are reviewing medical records from about 2,000 patients with triple-negative breast cancer who received pembrolizumab plus chemotherapy before surgery. The study measures how many patients had no detectable cancer left in their breast and lymph nodes at surge…
Sponsor: Yeon Hee Park • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can naming your feelings predict back pain relief?
Knowledge-focused Not yet recruitingResearchers at Marmara University are studying why some people with chronic low back pain and nerve-related leg pain respond better than others to a standard steroid injection near the spine. The team follows 60 adults who are already scheduled for this routine procedure. Before …
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Arkansas study tracks Moms' diets to boost baby health
Knowledge-focused Not yet recruitingThis study follows 125 pregnant women from 30 weeks of pregnancy through their baby's first year. Researchers want to learn how diet, food access, and other social factors affect mothers' health, breastfeeding success, and baby growth. Participants will complete remote visits and…
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
Knowledge-focused Not yet recruitingResearchers are observing 300 adults aged 60 and older with inflammatory bowel disease who are starting an advanced therapy chosen by their usual care team. The study tracks immune-aging markers such as CD4/CD8 ratio and IL-6, along with frailty and nutrition, over 52 weeks. The …
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Do GLP-1 Weight-Loss drugs change how teens eat and feel?
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are following 100 adolescents and young adults, ages 12 to 21, who are starting GLP-1 weight-loss drugs like Ozempic, Wegovy, or Mounjaro. Over one year, participants answer online surveys about their eating behaviors and…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Your phone might notice Alzheimer's decline before you do
Knowledge-focused Not yet recruitingResearchers at Poitiers University Hospital are studying whether changes in how people with Alzheimer's use their smartphones track with changes in their ability to handle daily tasks. About 100 participants aged 60 and older will have their Android phone usage and battery data c…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a questionnaire reveal how many mothers carry trauma from childbirth?
Knowledge-focused Not yet recruitingResearchers at Emile Muller Hospital in Mulhouse, France, want to estimate how many mothers develop post-traumatic stress disorder after giving birth. About 1,000 women who deliver at the hospital are asked to fill out the City Birth Trauma Scale and a short survey about their he…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Timing of kidney dialysis in ICU: could earlier start save days?
Knowledge-focused Not yet recruitingThis study looks at over 500,000 critically ill adults in Swedish ICUs to see if starting continuous kidney dialysis (CRRT) earlier affects how long they stay in the ICU. About 5% of these patients receive CRRT. Researchers will compare early versus late initiation of dialysis an…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
French study to reveal who really benefits from obesity drug semaglutide
Knowledge-focused Not yet recruitingThis study will follow 3,000 French patients with severe or complicated obesity who are taking semaglutide (Wegovy) as part of an early access program. Researchers will track weight changes, treatment patterns, and well-being over time using questionnaires. The goal is to underst…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Walking memory tests may reveal early Parkinson's clues
Knowledge-focused Not yet recruitingResearchers are studying whether navigational memory fades before other spatial memory in people with Parkinson's disease and related conditions. The pilot includes 80 participants: those with mild or advanced Parkinson's, those with parkinsonism, and healthy volunteers. Particip…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
30 patients to test if nutrition tracking boosts wound healing
Knowledge-focused Not yet recruitingThis pilot study will check if it's possible to collect useful nutrition and health information from 30 adults with diabetic foot ulcers. Researchers want to see if they can recruit enough people and gather complete data. The goal is to learn about patients' diet, body compositio…
Sponsor: Hvidovre University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
Knowledge-focused Not yet recruitingThis study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
China builds national watchdog for brain blood vessel devices
Knowledge-focused Not yet recruitingResearchers at Changhai Hospital are setting up a nationwide system to monitor how well devices and procedures for cerebrovascular conditions perform after they reach the market. The study plans to enroll about 2,000 adults with acute ischemic stroke, narrowed brain or neck arter…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Which contact method best warns families of hidden cholesterol danger?
Knowledge-focused Not yet recruitingThis study compares two approaches to notify relatives of people diagnosed with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. One method lets patients share information themselves; the other has the study team contact relatives directly. R…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Two autoimmune conditions, one child: study probes hidden thyroid trouble
Knowledge-focused Not yet recruitingAutoimmune hepatitis makes a child's immune system attack their liver. Researchers at Assiut University Children's Hospital want to know how many children with this liver condition also develop thyroid disorders such as Hashimoto thyroiditis or Graves' disease. The team will test…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Fitbit study aims to decode recovery after breast reconstruction
Knowledge-focused Not yet recruitingThis study will give 50 women a Fitbit Inspire 3 to wear before and after DIEP flap breast reconstruction surgery. Researchers will track steps, heart rate, and sleep, and compare that data with short questionnaires about recovery. The goal is to learn more about how patients rec…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New survey aims to better understand ovarian cancer Patients' daily lives
Knowledge-focused Not yet recruitingThis study is testing a new questionnaire (called the QLQ-OV39) to see how well it measures quality of life in people with ovarian cancer. About 50 adults with early or advanced ovarian cancer will fill out the questionnaire and give feedback. The goal is to make sure the questio…
Sponsor: Helios University Hospital Wuppertal • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a smartwatch help cancer patients during chemo and radiation?
Knowledge-focused Not yet recruitingThis study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploadi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a migraine pill sway the Body's balance reflex?
Knowledge-focused Not yet recruitingResearchers want to know whether CGRP, a protein involved in migraine, also affects the vestibulo-ocular reflex, the automatic eye movement that keeps vision steady when the head turns. The trial gives 80 people at the University Hospital Zurich either a single dose of atogepant,…
Phase 4 • Sponsor: Konrad Peter Weber • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Migraines and tension headaches may be hidden companions to multiple sclerosis
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are studying how often adults with multiple sclerosis also get primary headaches such as migraine and tension-type headache. About 100 patients will complete a single visit that includes a neurological exam, headache history, disability …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study to define healthy blood clotting ranges for kids
Knowledge-focused Not yet recruitingThis study will measure normal blood clotting values in 240 children under 18 who are having surgery or a procedure with anesthesia. The goal is to establish reference ranges for the Quantra system, a device that checks how well blood clots. This information will help doctors bet…
Sponsor: HemoSonics LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The hidden handshake that decides whether an embryo implants
Knowledge-focused Not yet recruitingResearchers want to understand why most IVF embryo transfers fail to implant and what goes wrong in pregnancies complicated by preeclampsia. They will collect small tissue samples from the womb lining of up to 500 women aged 18 to 50 who are already scheduled for a diagnostic hys…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists to examine liver tissue after gene therapy for hemophilia
Knowledge-focused Not yet recruitingThis observational study will take small liver samples from 8 adults with hemophilia A or B who had gene therapy at least 6 months ago. Researchers want to see how the gene therapy affected liver cells, including how many cells still carry the therapy and whether there is any liv…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
Knowledge-focused Not yet recruitingMultiple myeloma is a blood cancer in which abnormal plasma cells build up in bone marrow, and inflammation may shape how the disease behaves. Researchers at Assiut University plan to study 60 people newly diagnosed with myeloma before any anti-myeloma treatment begins. They will…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brain waves may reveal which children recover from encephalopathy
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are studying whether abnormal brain-wave patterns on an EEG can predict how well children with encephalopathy recover. The study follows 147 children aged 1 month to 18 years who have altered consciousness from encephalopathy. Ea…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can gene therapy zolgensma safely improve motor skills in SMA?
Knowledge-focused Not yet recruitingThis study follows 80 people with spinal muscular atrophy (SMA) in Japan who receive Zolgensma (onasemnogene abeparvovec) as an intrathecal injection. The goal is to track safety issues, such as liver problems or blood clotting abnormalities, and to measure changes in motor funct…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can Real-World data reveal the best rectal cancer treatment?
Knowledge-focused Not yet recruitingThis observational study gathers information from routine care on how localized rectal cancer is treated across Austrian hospitals. It aims to document the variety of treatment approaches, including total neoadjuvant therapy and immunotherapy, and their outcomes. By analyzing thi…
Sponsor: Austrian Breast & Colorectal Cancer Study Group • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can exercise shield the eyes of glaucoma patients?
Knowledge-focused Not yet recruitingResearchers at Shanghai General Hospital are studying whether exercise relates to visual function in people with glaucoma. About 100 patients aged 18 to 100 answer a questionnaire about their physical activity. The team then measures central visual field, retinal nerve fiber laye…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Your smartwatch could predict blood sugar crashes before they happen
Knowledge-focused Not yet recruitingThis study will test whether combining continuous glucose monitor (CGM) data with information from a smartwatch and a phone app (like meals and activity) can better predict blood sugar levels in people with type 2 diabetes. Thirty-six adults will wear a CGM and smartwatch and log…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Could we ditch antibiotics after a burst appendix? new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at whether it is safe to stop giving antibiotics after surgery for a burst (perforated) appendix. About 100 adults will be randomly assigned to receive either antibiotics or no antibiotics after their operation. The main goal is to see if a larger study is …
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Triple-Pronged attack on gut inflammation put to the test
Knowledge-focused Not yet recruitingResearchers are testing whether blocking three inflammation pathways at once (TL1A, IL-23, and α4β7) calms inflamed intestinal tissue more effectively than blocking each pathway alone. The study enrolls 30 people: 10 with ulcerative colitis, 10 with Crohn's disease, and 10 withou…
Sponsor: PhoenixLAB srls • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The clotting test that could reshape warfarin care in egypt
Knowledge-focused Not yet recruitingPeople with rheumatic heart disease and atrial fibrillation take warfarin to prevent strokes, but the drug only works safely when blood clotting stays in a narrow target range. Researchers at Assiut University are studying about 90 Egyptian adults on warfarin for at least six mon…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
AI nutrition coach for Moms-to-Be: a new study tests a Chatbot's helpfulness
Knowledge-focused Not yet recruitingThis study will test if an AI chatbot can give helpful nutrition advice to pregnant women. About 100 women will either use the chatbot or get standard care. The goal is to see if the chatbot is easy to use and if it helps improve diet and knowledge about conditions like gestation…
Sponsor: Hong Kong Metropolitan University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can modern heart failure drugs reverse damage in three months?
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are following 250 adults with chronic heart failure and reduced ejection fraction who are on or starting guideline-directed medical therapy. Over three months, the team measures changes in heart pumping function, kidney filtration, quali…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study tracks hidden dangers of common leukemia drug
Knowledge-focused Not yet recruitingThis study will follow 200 children with acute lymphoblastic leukemia or lymphoma to learn more about the short- and long-term side effects of asparaginase drugs. Researchers will track how often serious toxicities occur during standard treatment and a newer therapy called SJALL2…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Inside the metabolic chamber: scientists probe extreme obesity
Knowledge-focused Not yet recruitingThis study will measure how the body uses energy and burns fat in 10 people with extreme obesity (BMI of 60 or higher). Participants will spend 23 hours in a special metabolic chamber and drink a labeled water to track energy use over a week. The goal is to better understand meta…
Sponsor: Pennington Biomedical Research Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The 20-Minute squeeze: how eye injections push pressure up
Knowledge-focused Not yet recruitingAnti-VEGF injections treat conditions like diabetic macular edema, age-related macular degeneration, and retinal vein occlusion by adding fluid inside the eye, which can briefly raise eye pressure. This observational study at Assiut University follows 50 adults receiving these ro…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple questionnaire improve sleep apnea treatment?
Knowledge-focused Not yet recruitingThis study tests whether a new questionnaire called PLATO can help dentists track how well oral appliance therapy works for people with obstructive sleep apnea. The questionnaire, developed by the American Academy of Sleep Medicine, measures patient-reported outcomes. Researchers…
Sponsor: Nevada Dental Sleep • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC